Sleep Apnea

Sleep Apnea

Contributor(s): Dr. Maureen Williams, ND

1 Overview

Summary and Quick Facts

  • Sleep apnea is breathing interruptions during sleep. These interruptions cause us to wake up numerous times during the night. Sleep apnea is linked to heart disease, diabetes, poor cognitive function and many other health concerns.
  • In this protocol, learn about the different kinds of sleep apnea and why it is so important to have it properly diagnosed and treated. Also learn about lifestyle and dietary habits that may help improve it. Dietary supplements that address some of the factors that contribute to sleep apnea will be reviewed, as well.
  • Effective sleep apnea treatments are available, and they can greatly improve quality of life. But many people either don’t seek treatment or give up quickly due to inconvenience or discomfort. It’s important to work with a qualified sleep specialist to find the right solution for you, which may take trial and error.

Sleep apnea is an increasingly common but underdiagnosed disorder characterized by repeated pauses in breathing during sleep that can lead to the following serious health problems:

  • cardiovascular disease
  • type 2 diabetes
  • cancer
  • gout
  • cognitive dysfunction
  • increased risk of dying from any cause

Fortunately, integrative interventions like N-acetyl-cysteine (NAC) and coenzyme Q10 can improve sleep quality and respiratory function in patients with sleep apnea.

Risk Factors for Developing Sleep Apnea

  • Overweight and obesity
  • Smoking
  • Allergies and asthma

Signs and Symptoms Associated with Sleep Apnea

  • Snoring
  • Pauses in breathing
  • Intermittent waking and insomnia

Conventional Medical Treatments

  • CPAP (continuous positive airway pressure)
  • Other oral appliances to help keep the upper airway open  
  • Surgery for when the obstruction is due to an anatomical problem, such as enlarged tonsils or adenoids  

Novel and Emerging Therapies

  • Estrogen and progesterone for women
  • Hypoglossal nerve stimulation
  • Renal denervation
  • Nasal continuous positive airway pressure and oral pressure therapy

Dietary and Lifestyle Changes

  • Obesity is the most important major modifiable risk factor associated with obstructive sleep apnea; therefore, weight loss is an important intervention.
  • Exercising 2.5‒4 hours per week may reduce severity and symptoms of sleep apnea even without weight loss.

Integrative Interventions

  • N-Acetyl-Cysteine (NAC): NAC has mucus-reducing properties that have been shown to cause significant improvements in measurements of apnea severity and sleep quality.
  • Vitamin C: Improves endothelial health of sleep apnea patients and reduces episodes of sleep apnea and daytime sleepiness along with vitamin E.
  • Vitamin E: Shown to reduce episodes of sleep apnea and daytime sleepiness along with vitamin C as well as improve respiratory function in combination with other antioxidants.
  • Coenzyme Q10 (CoQ10): Improves respiratory function in combination with other antioxidants in patients with sleep apnea. Patients with sleep apnea are at increased risk for cardiovascular disease, and CoQ10 supplementation may confer a benefit in cardiovascular disease.
  • Selenium: Patients with lower red blood cell selenium levels were found to have more severe sleep apnea, as measured by the apnea-hypopnea index.

2 Introduction

Sleep apnea is an increasingly common and often overlooked disorder characterized by repeated pauses in breathing during sleep (Jordan 2014; Hayes 2014; Strohl 2013). These frequent respiratory pauses result in periods of low blood oxygen levels, nervous system dysfunction, and sleep fragmentation, leading to an array of serious health problems. In fact, an abundance of research shows that sleep apnea considerably increases the risk of dying from any cause (Panossian 2013; Kendzerska 2014).

Sleep apnea is an under-recognized but growing epidemic with alarming public health implications. The National Sleep Foundation estimates that more than 18 million people in the United States have sleep apnea, but this insidious condition is believed to be vastly underdiagnosed (NSF 2014; Ramirez 2013; Paiva 2014; Yu 2011; Peppard 2013; Hayes 2014; Motamedi 2009).

There are many consequences of untreated sleep apnea, including the hallmarks of chronic sleep deprivation: daytime sleepiness, cognitive difficulties, depression, and increased risk of accidents and injuries (Seneviratne 2004; Hayes 2014; NSF 2014; Thompson 2012; NIH 2006; Ellen 2006; Findley 1991; Mayo Clinic 2012). In addition, a significant and growing list of serious chronic ailments have been associated with sleep apnea, including cardiovascular and neurological diseases, pregnancy complications, obesity, bleeding peptic ulcers, and insulin resistance and type 2 diabetes (Paiva 2014; Jordan 2014; UMMC 2013b; Mirrakhimov 2013; Hayes 2014). Researchers are also investigating possible associations between sleep apnea and autoimmune diseases, osteoporosis, and even cancer (Kang 2012; Mirrakhimov 2013; Yen 2014; Noguti 2013; Pamidi 2014).

The first-line treatment approach for obstructive sleep apnea is a device that provides continuous positive airway pressure, known as CPAP (NSF 2014; Hayes 2014). The device is worn during sleep and introduces mildly pressurized air into the airways to keep them open (Mayo Clinic 2012; NSF 2014). The benefits of CPAP are particularly evident in those with sleep apnea who experience excessive daytime sleepiness (Chiner 2013). Moreover, research suggests CPAP use might improve markers of cardiovascular health and glucose metabolism for those with sleep apnea (Monahan 2011; Gottlieb 2014; Gallegos 2014; Chen, Pei 2014; Schlatzer 2014; Ayas 2006).

Some patients are unable to tolerate CPAP, in which case other therapies may be considered. Dental devices and surgical procedures to open the airway may be beneficial in some people with sleep apnea. Other methods sometimes recommended include bariatric weight loss surgery and negative pressure devices (Freedman 2014; Hayes 2014).

Dietary and lifestyle interventions can have a significant impact on the severity and consequences of sleep apnea. Weight loss is the most common and well-supported adjunct to CPAP, and it can be effective on its own (Hayes 2014; UMMC 2013a; Thompson 2012). Exercise, even without weight loss; correct sleep position; avoidance of alcohol and sedatives before bed; and a generally healthy diet are important for managing sleep apnea (UMMC 2013b; Hayes 2014). Integrative interventions may both reduce the severity of sleep apnea and help minimize the consequences of some of the serious conditions associated with sleep apnea (Grebe 2006; Singh 2009; Sadasivam 2011; Lee 2009).

In this protocol, you will learn about the causes of sleep apnea and factors that increase sleep apnea risk. Conventional treatment approaches will be reviewed, as will several novel and emerging treatment strategies. A number of lifestyle considerations and natural, integrative interventions that may lessen the impact of sleep apnea will be discussed as well.

3 Background

Sleep apnea is divided into two types: obstructive and central, with obstructive being much more common (UMMC 2013a; NSF 2014). In obstructive sleep apnea, the airways collapse and block airflow episodically during sleep. In central sleep apnea, the respiratory control centers in the brain do not provide sufficient stimulation to maintain regular breathing during sleep. However, it appears that elements of both obstructive and central mechanisms occur simultaneously in some people with sleep apnea (Ramirez 2013; Khan 2014; ASAA 2014; Hoffman 2012; Lehman 2007).

Obstructive Sleep Apnea

Swelling, narrowing, or anatomical abnormalities of structures of the air passageway can obstruct airflow, causing a pause in respiration that must be overcome by strong signals from the brain’s respiratory center to trigger inhalation (Jordan 2014; Schwab 2011; ATS 2014). Posture often plays a crucial role in obstructive sleep apnea; the gravitational pull associated with a back-sleeping position can cause an increased tendency for the airway to collapse and block airflow (Bilston 2014).

Central Sleep Apnea

The involuntary breathing reflex is regulated by the brain in response to blood carbon dioxide levels. Normally, as blood carbon dioxide levels rise, the respiratory center of the brain triggers increased breathing (Nattie 1999; Guyton 1990). In central sleep apnea, the brain does not adequately regulate breathing. Central sleep apnea is often caused by another health condition. For instance, central sleep apnea is common in congestive heart failure and with chronic opioid drug use (Javaheri 2013; Floras 2014). Central sleep apnea can also occur without a clear cause (Ramirez 2013; ASAA 2014).

Mixed or Complex Sleep Apnea

Mixed sleep apnea, sometimes referred to as complex sleep apnea, involves both obstructive and central components. Up to18% of people with sleep-disordered breathing—the broad category that includes apneas as well as less severe hypopneas (shallow and/or slow breathing)—may have mixed sleep apnea. In a significant percentage of cases, central apnea is revealed during treatment of the obstructive aspect of sleep apnea with CPAP (Khan 2014; Hoffman 2012; Lehman 2007).

Association with Other Diseases

Sleep apnea is associated with a number of serious conditions (Thompson 2012; Martinez Ceron 2014; Yu 2011; Canales 2008):

Cardiovascular disease. Intermittent hypoxia (periods of low oxygen levels) caused by sleep apnea can contribute to chronic high blood pressure and endothelial damage (Ziegler 2011). People with obstructive sleep apnea are more likely to suffer from high blood pressure, coronary artery disease, and abnormal heart rhythms, and they have a higher risk of heart failure, heart attack, and stroke (Jean-Louis 2008; Gottlieb 2013; Pepin 2014; Ali 2014; Hohl 2014; Oldenburg 2014).

Type 2 diabetes and obesity. Up to 40% of people with obstructive sleep apnea have type 2 diabetes, and as many as 53% of overweight or obese people with type 2 diabetes have obstructive sleep apnea (Bonsignore 2013; Nannapaneni 2013). Sleep apnea is also independently associated with insulin resistance (Martinez Ceron 2015). Obesity in general, and especially abdominal or central obesity, is a major risk factor for obstructive sleep apnea (Hoffstein 1992; Schwartz 2008; Thompson 2012; Stadler 2009; Hayes 2014).This relationship between obesity and obstructive sleep apnea appears to be bidirectional. While obesity likely plays a causal role in obstructive sleep apnea, sleep apnea may contribute to weight gain (Romero-Corral 2010; Pillar 2008; Yu 2011).

Cancer. In a study that followed 386 adults over 20 years, moderate-to-severe obstructive sleep apnea was associated with a 2.5 times higher risk of new cancer diagnosis and a 3.4 times higher risk of cancer death (Marshall 2014). In another study, individuals with mild sleep disordered breathing (SDB) had 1.1 times the risk of dying of cancer, those with moderate SDB had 2 times the risk, and those with severe SDB had 4.8 times the risk, compared with healthy subjects (Nieto 2012).

Gout and hyperuricemia. Gout is a painful arthritic condition caused by an excess of uric acid in the blood (hyperuricemia), which accumulates as crystals in the joints (NLM 2014). People with gout appear to be at increased risk of sleep apnea (Roddy 2013). Furthermore, individuals with high uric acid levels have been shown to be more likely to snore more than five nights per week and to experience daytime sleepiness (Wiener 2012). Uric acid level is known to rise in concert with increasing frequency of apneic episodes and has been suggested to be a marker of sleep apnea severity (Cantalejo Moreira 2013; Hirotsu 2013; Kanbay 2014; Wiener 2012).

Cognitive and neurological problems. Studies suggest chronic sleep deprivation and interruption may increase the risk of chronic cognitive problems and neurological disease, including Alzheimer’s disease (Lucey 2014; Buratti 2014).

Pregnancy complications. Obstructive sleep apnea is common in pregnancy, and symptoms associated with sleep apnea such as snoring generally worsen as pregnancy progresses (Sarberg 2014; Calaora-Tournadre 2006; Facco 2012; Sahota 2003; Lefcourt 1996). A rigorous scientific literature analysis concluded that, in pregnant women, sleep disordered breathing—a designation for a group of related conditions that includes sleep apnea—is associated with a 2.34-fold increased risk of gestational high blood pressure and a 1.86-fold increased risk of gestational diabetes compared with those without sleep apnea (NIDDK 2013; NLM 2015b).

Erectile dysfunction. It has been estimated that half of men with sleep apnea also have erectile dysfunction, and vice versa. This association could be explained by dysfunction of the cells lining the insides of blood vessels (endothelial dysfunction), a condition common to both erectile dysfunction and obstructive sleep apnea (Hoyos, Melahan, Phillips 2014).

Low testosterone levels. Several studies have confirmed that serum testosterone levels are lower in men with obstructive sleep apnea. A study that compared 36 men with stable mild-to-severe obstructive sleep apnea to healthy controls found that lower serum testosterone levels were associated with greater sleep apnea severity and body mass index (Canguven 2010). One study found that men with obstructive sleep apnea had 17% lower serum testosterone levels than controls (Bercea 2014); another found that obese men with severe obstructive sleep apnea had significantly lower testosterone levels than matched, healthy controls, and that lower testosterone was significantly correlated with symptoms of depression in the obstructive sleep apnea group (Bercea 2013).

Systemic conditions. Obstructive sleep apnea and accompanying intermittent hypoxia are associated with increased oxidative stress, systemic inflammation, and endothelial dysfunction (Alzoghaibi 2012; Badran 2014; Nadeem 2013; Chen 2013; Hoyos, Melehan, Liu 2014; Drager 2013; Ziegler 2011).

Other conditions. In a five-year study following 1411 people with obstructive sleep apnea and 7055 without, obstructive sleep apnea was associated with 1.9 times the risk of developing an autoimmune disease (Kang 2012). Obstructive sleep apnea has also been associated with depression, glaucoma, interstitial cystitis, and chronic kidney disease (Chung 2014; Lin 2011; Perez-Rico 2014; Cross 2008; Dantzer 2008; Adeseun 2010; Chou 2011).

4 Risk Factors

Overweight and Obesity

Obesity is the clearest risk factor for obstructive sleep apnea. However, patterns of fat distribution may affect men and women differently. In 151 patients undergoing sleep studies, neck and waist circumference, and waist-to-hip ratio were evaluated. In men, neck circumference and waist-to-hip ratio were significantly associated with the apnea-hypopnea index, a measure of sleep apnea severity. In women, only waist-to-hip ratio was significantly associated with apnea-hypopnea index (Lim 2014; Ayas 2014).


Smoking increases the risk of obstructive sleep apnea, and of developing obstructive sleep apnea at an earlier age than people who never smoked. Cigarette smoking increases upper airway resistance as a result of inflammation, swelling and increased mucus secretion, which may explain this association (Boussoffara 2013; Hizli 2013; Quan 2014; Lin 2012).

Allergies and Asthma

In a study in over 1900 individuals, the combination of asthma and allergic rhinitis was associated with 1.44-fold increased odds of obstructive sleep apnea compared to those with just asthma. When allergic rhinitis duration and severity were taken into account, the odds rose to 1.99-fold. The authors concluded that allergic rhinitis, independent of obesity and other risk factors, contributes to the risk of sleep apnea (Braido 2014).

Gender and Ethnicity

Men are at twice the risk of obstructive sleep apnea compared with women (Sutherland 2012; Valipour 2012). African American men under age 39, and between 50 and 59, have more severe sleep apnea compared with white men of the same age (Pranathiageswaran 2013; Sutherland 2012). In Asians, the association of obstructive sleep apnea with obesity is not as strong as in other ethnicities (Chirakalwasan 2013).


The risk of sleep apnea increases with age. This may be due to factors such as diminished efficiency of muscles and soft tissues in the upper airway or reduced sleep quality (Jordan 2014).

Declining Hormone Levels (in Women)

The risk of sleep apnea increases significantly after menopause, and some evidence suggests female reproductive hormones play a protective role against obstructive sleep apnea (Dursunoglu 2009; Tamanna 2013; Keefe 1999; Dancey 2001; Tasali 2008). Indeed, a preliminary study showed that estradiol plus progestin therapy or estradiol alone reduced the severity of sleep apnea in five postmenopausal women (Keefe 1999).

Family History and Narrow Airways

Obstructive sleep apnea may have a hereditary component, perhaps because its risk factors also run in families (Hayes 2014; Thompson 2012). These include anatomical features of the airway and obesity (Redline 1995; Jordan 2014).

5 Signs and Symptoms

Sleep apnea often goes undiagnosed largely because the direct symptoms are witnessed only by bedmates, and the indirect symptoms, those related to sleep deprivation, can be vague or attributable to many possible causes (Ho 2011). The most common sleep apnea symptoms include (Lal 2012; Mayo Clinic 2012; Karacan 1995):

  • Snoring. Loud snoring often indicates the presence of sleep apnea, and it is more pronounced in obstructive sleep apnea. Apneas may also interrupt snoring and cause the patient to snort.
  • Pauses in breathing. Sleep apnea often causes pauses in breathing during sleep that are noticed by another person. Someone with sleep apnea may pause breathing for a period during sleep then gasp for air.
  • Intermittent waking and insomnia. It may be difficult to remain asleep. Patients may also awake suddenly with shortness of breath.
  • Dry mouth, sore throat, and headache upon waking.
  • Fatigue and excessive daytime drowsiness. Patients with sleep apnea are susceptible to falling asleep at work and while driving.
  • Attention, learning and memory difficulties. This can include difficulty concentrating, reasoning, and paying attention. 
  • Feeling moody, depressed, or irritable.
  • Sexual dysfunction. Lack of libido and impotence are common concerns in people with sleep apnea.

6 Diagnosis


Given the high prevalence of sleep apnea and its association with serious health conditions, simple clinical screening for obstructive sleep apnea in high-risk groups is important. Symptoms such as snoring, excessive daytime sleepiness, and reports of sleep disordered breathing accompanied by obesity, cardiovascular disease, type 2 diabetes, or metabolic syndrome are likely to indicate candidates for further screening or intervention (Seetho 2013). Before diagnosing sleep apnea, physicians must rule out a number of other conditions that can cause similar symptoms (Gutierrez 2013).

Various screening questionnaires have been developed in order to predict the existence and severity of obstructive sleep apnea, as well as the likelihood of clinical complications of obstructive sleep apnea in pre-surgical and hospital settings. One of the most well validated is STOP-BANG, which stands for “Snoring, Tiredness during daytime, Observed apnea, high blood Pressure, Body mass index, Age, Neck circumference, and Gender” (Braido 2014). A STOP-BANG score of three or more (out of eight) is a sensitive indicator of obstructive sleep apnea, while a score of six out of eight is a highly specific indicator of severe obstructive sleep apnea (Chung 2013; Proczko 2014; Chung 2012; Silva 2011).


The definitive test for sleep apnea is an overnight polysomnography, often called a sleep study. This test is done in a laboratory and monitors the occurrence of apneic (paused) and hypopneic (shallow and/or slow) breathing episodes by measuring respiratory effort, airflow, and blood oxygen saturation. Polysomnography also includes neurological testing to monitor limb movements, body position, and the sleep-wake state (Jordan 2014).

The accepted criterion for a diagnosis of sleep apnea is five or more episodes of apnea or hypopnea per hour lasting for 10 or more seconds each. Diagnosis of mild, moderate, or severe sleep apnea is based on clinical presentation and sleep study results (De Backer 2013).

American Academy of Sleep Medicine Obstructive Sleep Apnea Classifications (Gutierrez 2013)



Clinical presentation and associated risks


5–15 episodes per hour

  • Mild sleepiness or insomnia
  • Mildly low oxygen levels
  • Benign cardiac arrhythmias


15–30 episodes per hour

  • Moderate daytime sleepiness, fatigue that interferes with normal daily activities
  • Moderately low oxygen levels and/or mild cardiac arrhythmias
  • At risk for injuries/accidents
  • At risk for high blood pressure, heart attack, stroke and right-sided heart failure


>30 episodes per hour and/or hypoxia <90% for >20% of total sleep time

  • Daytime sleepiness interferes with normal daily activities
  • Severely low oxygen levels
  • Moderate-to-severe cardiac arrhythmias
  • At risk for injuries/accidents
  • At significant risk for high blood pressure, heart attack, stroke, and right-sided heart failure

*AHI, apnea-hypopnea index
** Patients with mild obstructive sleep apnea (ie, 5–15 episodes per hour) may be asymptomatic.

Because polysomnography is cumbersome, expensive, and inconvenient, portable monitoring devices are sometimes used in the home to aid in diagnosis. Two examples of portable devices that have been found comparable to polysomnography, and which, in the future, may be useful as stand-alone diagnostic tools, are a portable pulse oximeter, which can attach to a finger and non-invasively measure oxygen saturation as it rises and falls during sleep (Romem 2014), and a peripheral arterial tonometer, which measures changing vascular tone (Yalamanchali 2013).

7 Conventional Treatments

CPAP: Continuous Positive Airway Pressure

CPAP is first-line treatment for obstructive sleep apnea (Phillips 1990; Elshaug 2008; Almeida 2013). Numerous studies show that this method of applying constant mild air pressure to the airway during sleep reduces apneic (paused) and hypopneic (light) breathing and helps relieve signs and symptoms of sleep loss like fatigue, drowsiness, and cognitive and mood changes (Weaver 2012; Engleman 1993; Sanchez 2009; Kushida 2012; Ferini-Strambi 2003; Tomfohr 2011; Lau 2013). A 2013 review indicates that the more hours per night the device is used, the greater the benefit (Wickwire 2013).

Several studies have found that treatment of sleep apnea with CPAP can improve cardiac function and insulin sensitivity; and reduce heart rate, blood pressure, and cardiovascular mortality (Hassaballa 2005; Fava 2014; Aggarwal 2014; Ge 2013; Cordero-Guevara 2011; Marin 2005). An analysis of prior research found a trend for CPAP use to reduce the risk of death due to cardiovascular events in people with sleep apnea (Ge 2013).

There have been mixed results in studies looking at the effect of CPAP on blood glucose control, but it appears that people with severe sleep apnea are the most likely to experience a benefit in blood glucose management with CPAP (Bonsignore 2013). A rigorous review of studies examining CPAP and glycemic control concluded that most studies show that CPAP improves insulin sensitivity and markers of long-term glucose control in people with sleep apnea and type 2 diabetes or pre-diabetes. The best effect was seen after three months of nightly use for four or more hours per night (Gallegos 2014).

One barrier to consistent CPAP use is comfort (Beecroft 2003; Ballard 2007; Weaver 2010). It is estimated that only 70% of people to whom CPAP is recommended actually begin treatment with it, and of those who do, only 50% continue long term. Furthermore, many people are unsuccessful at using CPAP for the recommended number of hours during sleep. Fortunately, technological advances intended to improve patient comfort are under development (Wickwire 2013).

People who tolerate the CPAP mask and straps but find the constant air pressure uncomfortable may prefer one of two other options for positive airway pressure. The first is called bilevel positive airway pressure, or BiPAP. With BiPAP therapy, a lower level of air pressure is used during expiration, and a higher level during inspiration. This may improve comfort, especially for people who use higher pressure settings with CPAP and have trouble exhaling against the pressure. The second is called automatic positive airway pressure, or APAP. With APAP therapy, the device automatically adjusts its pressure output to the pressures it senses during the breathing cycle. APAP may be more comfortable for people whose apnea occurs mainly in certain sleep positions (Stasche 2006).

Other Oral Appliances

Oral appliances, or dental devices, are used during sleep to physically keep the upper airway open by either holding the lower jaw forward or moving the tongue forward (Hoffstein 2007; Chan 2007). These devices are usually custom-fitted by a dentist and are more likely to be helpful in people who have mild-to-moderate sleep apnea, are younger, less overweight, and have a smaller neck circumference (Remmers 2013; Hoffstein 2007). Although less effective than CPAP, oral appliances are sometimes used in those who are unable to tolerate CPAP (Gutierrez 2013; Freedman 2014).


A rigorous literature review published in 2013 concluded that there was not adequate evidence to support the recommendation of any specific drug for the treatment of obstructive sleep apnea, though many trials have attempted to study medications for this purpose (Mason 2013). However, central sleep apnea may respond to medications that stimulate breathing or promote sedation. Evidence in support of pharmacological treatment of central sleep apnea is sparse. Modafinil (Provigil) has been approved for daytime sleepiness in patients with sleep apnea. Other medications that are sometimes prescribed, but are not FDA-approved for sleep apnea, include acetazolamide (Diamox) and theophylline, to stimulate breathing, as well as the sedatives temazepam (Restoril) and zolpidem (Ambien) (Becker 2014; Mayo Clinic 2013; Seda 2014; Eckert 2014; Dopp 2010; Launois 2013; Kielb 2012).

Some people with obstructive sleep apnea continue to suffer with excessive daytime sleepiness in spite of CPAP therapy or other treatments. Modafinil is a wakefulness-promoting medication that is effective in relieving daytime sleepiness in people with obstructive sleep apnea (Inoue 2013; Bittencourt 2008; Black 2005). Common side effects of modafinil include anxiety, headache, nausea, and nervousness (NLM 2015a).


Surgery can be an important part of the treatment approach to sleep apnea when the obstruction is due to an obvious anatomical problem, such as enlarged tonsils or adenoids, or a deviated septum. There is considerable variability in the success rate of sleep apnea surgery, with estimates of benefit ranging from as low as 35% to as high as 92% (Li 2008; Camacho 2013; Kotecha 2014; Tien 2014; Khirani 2012). Surgical techniques can attempt to open the airway and decrease collapsibility. A combination of surgical methods may be recommended in some cases (Handler 2014; Tien 2014).

8 Novel and Emerging Strategies

Sex Hormones

Estrogen and progesterone. Interaction between sleep apnea and steroid hormones may partially explain the gender discrepancy in sleep apnea incidence. Female reproductive hormones appear to be protective against sleep apnea (Dursunoglu 2009; Tasali 2008). Postmenopausal women and women with polycystic ovary syndrome, two conditions marked by low estrogen and progesterone levels, are much more likely to have sleep apnea than healthy women in their reproductive years (Ehrmann 2012; Valipour 2012; Tamanna 2013). Also, women with sleep apnea have been found to have lower levels of estrogen and progesterone than women without sleep apnea (Netzer 2003).

Researchers have examined the role of estrogen and progesterone therapy in the treatment of sleep apnea in postmenopausal women. A large observational study found that postmenopausal women using hormone therapy were 50% less likely to have sleep apnea than women who did not use hormones (Shahar 2003). In one preliminary trial, after just one week of treatment with a combination of 1.25 mg of premarin (conjugated equine estrogens) and 20 mg of the progestin (synthetic progesterone-like compound) medroxyprogesterone acetate, a reduction in the number of apneic episodes was observed in nine surgically postmenopausal women (Pickett 1989). In another preliminary study, five postmenopausal women with sleep apnea experienced a 25% drop in apnea severity after taking 2 mg of micronized estradiol for 3–4 weeks, and a subsequent 50% reduction in severity from baseline when 10 mg of medroxyprogesterone acetate was added (Keefe 1999).

In another small preliminary trial, six postmenopausal women with mild-to-moderate sleep apnea used a transdermal estradiol patch providing 50 mg of estradiol per day for two weeks, and then added 200 mg per day of oral micronized progesterone for another two weeks. The women slept better and had fewer apneic and hypopneic episodes during treatment with estradiol, but the addition of progesterone produced no additional benefit (Manber 2003). In a preliminary trial involving five peri- or postmenopausal women with sleep apnea, a daily oral combination of 2 mg of estradiol plus 0.5 mg of the progestin trimegestone was associated with a mean 75% drop in sleep apnea severity (Wesstrom 2005).

Although the exact mechanism by which estrogen and progesterone might exert beneficial effects in sleep apnea is not entirely clear, studies sugest these hormones may play a role in maintaining muscular tone in the upper airway (Popovic 1998; Hou 2010; Liu 2009). Using bioidentical hormones, which are identical to the hormones produced naturally by the body, is the preferred method of hormone replacement.

More information about hormone replacement therapy for women is available in the Female Hormone Restoration protocol.

Testosterone. Sleep quality and testosterone levels are related, especially in older men, an effect largely explained by body fat content (adiposity). In men with obstructive sleep apnea, weight loss consistently restores testosterone levels, while the effect of CPAP on testosterone restoration is inconsistent (Barrett-Connor 2008; Wittert 2014; Zhang 2014; Bercea 2012; Knapp 2014). In addition, some researchers have noted that “Measuring testosterone level may be an additional helpful indicator in diagnosis of severity and in follow-up of [obstructive sleep apnea]” (Canguven 2010).

Testosterone therapy may have some positive impacts on cardiovascular and metabolic health in men with sleep apnea (Hoyos, Yee 2012), but some evidence shows a worsening of sleep apnea severity with testosterone therapy (Grech 2014; Andersen 2008; Hoyos, Killick 2012; Matsumoto 1985). However, one study found that the negative impact of testosterone therapy on sleep apnea resolved by week 18, suggesting a transient nature for this effect (Killick 2013). Nevertheless, current guidelines recommend against testosterone replacement therapy in men with untreated severe obstructive sleep apnea (Bhasin 2010). But some researchers have questioned this position, stating the evidence is weak and inconsistent (Hanafy 2007).

One possible approach is for men with low testosterone levels and untreated sleep apnea to receive treatment for their sleep apnea before initiating testosterone replacement therapy. These men should also lose weight if they are overweight. If low testosterone levels persist after successful sleep apnea treatment, then testosterone replacement therapy might be a reasonable consideration. Men who do initiate testosterone therapy after successful sleep apnea treatment should be closely monitored for reemergence of sleep apnea.

A more detailed discussion about testosterone replacement is included in the Male Hormone Restoration protocol.

Hypoglossal Nerve Stimulation

The hypoglossal nerve is one of the 12 cranial nerves (Gillig 2010). When stimulated, the hypoglossal nerve increases muscle tone in the tongue (Huang 2004; Gilliam 1995). Because increased tongue muscle tone may reduce airway obstruction, a hypoglossal nerve stimulating device has been developed for the treatment of sleep apnea. This device is surgically implanted on the chest wall and is connected to one or two chest leads, which measure breath cycles, and to a lead that delivers electrical stimulation to the hypoglossal nerve in the neck (Strollo 2014).

Several studies have looked at the effect of hypoglossal nerve stimulation in people with sleep apnea who were unsuccessful in using CPAP. In general, these have been uncontrolled trials lasting for 6 to 12 months in people with moderate-to-severe apnea. Use of these nerve-stimulating devices was associated with high degrees of safety and compliance, reductions of greater than 50% in apneic and hypopneic episodes, decreases in symptoms of sleep apnea, and improvements in quality of life measures (Eastwood 2011; Van de Heyning 2012; Strollo 2014; Mwenge 2013; Kezirian 2014). Although early data indicate a promise of benefit, hypoglossal nerve stimulators are still being studied and are approved only for investigational use in the United States as of early 2015 (Oliven 2011; Freedman 2014).

Renal Denervation

In sleep apnea, sleep is fragmented, which causes chronic overstimulation of the sympathetic nervous system; in other words, a prolonged stress response (Adeseun 2010; Canales 2008). One way the body responds to stress is by raising blood pressure to ensure sufficient blood flow to tissues like the heart, muscles, and brain. This occurs in large part by means of sympathetic nerve signaling via the renal nerves; this signal triggers vasoconstriction and sodium and fluid retention, resulting in increased blood pressure (Dusek 2009; Kannan 2014). Thus, it follows that one of the most prevalent and serious conditions correlated with sleep apnea is resistant hypertension, which is high blood pressure that persists despite aggressive drug treatment (Pedrosa 2011; Parati 2014; AHA 2014). Renal denervation, a technique in which renal sympathetic nerve fibers are selectively removed, is a new strategy being explored for the treatment of resistant hypertension as well as sleep apnea (Kannan 2014; Ukena 2013).

Renal denervation has been found, in preclinical and clinical models, to not only lower blood pressure but also improve severity of obstructive sleep apnea (Bohm 2013; Zhao 2013; Witkowski 2011). One study compared the effects of renal denervation to CPAP treatment in patients with moderate-to-severe obstructive sleep apnea as well as high blood pressure. Both treatments had a positive impact on sleep apnea and hypertension (Zhao 2013). A rigorous analysis of research into renal denervation for obstructive sleep apnea was published in 2014. This analysis examined data from five separate studies, involving a total of 49 people, all of whom were followed for six months after renal denervation. In these patients, renal denervation was associated with a significant decrease in severity of obstructive sleep apnea (Shantha 2014).

By reducing elevated sympathetic tone, thus interrupting the stress response, renal denervation may reduce severity of obstructive sleep apnea, and have broad benefits for cardiovascular health, glucose control, and weight management (Thomopoulos 2013). In fact, one study in 10 subjects with sleep apnea and treatment-resistant hypertension reported improved glucose control as well as reduced blood pressure and sleep apnea severity six months after renal denervation (Witkowski 2011).

However, as of early 2014 the only randomized controlled trial conducted on renal denervation for resistant hypertension found no benefit from the procedure, with only poor quality, unblinded studies showing a positive effect—though analysis of the data continues. Renal denervation may be associated with renal artery stenosis, which can actually raise blood pressure (Mahfoud 2013; Kwon 2014; Boyles 2014; Mandrola 2014).

Nasal Expiratory Positive Airway Pressure and Oral Negative Pressure Therapy

Because many people find CPAP difficult to use, other devices working on the same principle—using air pressure to keep airways open—have been developed.

Nasal expiratory positive airway pressure. This treatment creates positive pressure only in the expiratory phase of the breath cycle, rather than continuously. The pressure is generated by adhesive nasal patches that function as one-way valves that close during exhalation, providing air resistance pressure. These nasal patches may be more tolerable to some people than a CPAP facemask. Expiratory positive airway pressure reduces frequency and duration of apneas in people with obstructive sleep apnea, but works best in mild cases, and compares poorly to CPAP in severe obstructive sleep apnea. Expiratory positive airway pressure is contraindicated for people with nasal obstruction, obstructive lung disease, blood gas abnormalities, or severe obstructive sleep apnea (Freedman 2014; De Dios 2012).

Oral negative pressure therapy. In this therapy, negative pressure is provided through an oral suction device that draws the soft palate forward, maintaining airway patency. In a preliminary trial, oral negative pressure therapy significantly reduced obstructive sleep apnea severity, improved sleep quality, and decreased symptoms in a subgroup of participants. People who had positive effects from this treatment generally did so from the first night of use, and people with severe, moderate, and mild sleep apnea had equal chances of benefiting (Colrain 2013).

9 Dietary and Lifestyle Considerations

Weight Loss

Weight loss has been demonstrated to decrease the severity of obstructive sleep apnea, and has been called “the most important major modifiable risk factor associated with obstructive sleep apnea.” A study in 690 adults found that a 10% weight loss was predictive of a 26% drop in apnea-hypopnea index, while a 10% weight gain predicted a 32% increase in apnea-hypopnea index (Peppard 2000; Araghi 2013; Mitchell 2014; Bonsignore 2013). Also, it may be easier for people with obstructive sleep apnea to lose weight when dietary weight loss measures are accompanied by CPAP (Bonsignore 2013).

A six-month randomized study in 40 obese subjects with moderate-to-severe obstructive sleep apnea found that a low-calorie Mediterranean diet, combined with increased physical activity, was more effective for both weight loss and reduction in severity of sleep apnea than a low-calorie diet with a smaller increase in physical activity (Papandreou 2012). The Mediterranean diet emphasizes whole grains, legumes, fruits, vegetables, nuts, and fish (OPT 2015). Mediterranean eating patterns have also been shown to benefit people with diabetes, as well as help reduce risk of diabetes, high blood pressure, cardiovascular disease, and many other conditions (Salas-Salvado 2014; Esposito 2014; Domenech 2014; Toledo 2013; Estruch 2013; Ajala 2013; Khatri 2014; Filomeno 2014; Lourida 2013).

A thorough discussion of weight loss strategies is included in the Weight Loss protocol.


Exercise, even without weight loss, appears to reduce severity and symptoms of obstructive sleep apnea (Iftikhar 2014). This was demonstrated in a study in 10 adult men and one adult woman who participated in a supervised exercise program of two hours twice weekly for six months. At enrollment, the participants already completed three months of CPAP, but the exercise program reduced a measure of respiratory disturbance (Giebelhaus 2000). Another study in subjects with obstructive sleep apnea found that a supervised exercise program involving 150 minutes per week of moderate intensity aerobic exercise plus strength training led to reductions in sleep apnea severity, depressive symptoms, and fatigue, and also improved daytime functioning (Kline 2012).


Acupuncture may benefit individuals with obstructive sleep apnea, reducing the number of apneic and hypopneic events and improving oxygen levels (Bo 2008; Freire 2007; Freire 2010; Xu 2009). In one randomized, placebo-controlled study, 36 subjects with sleep apnea were divided into three treatment groups: acupuncture, sham acupuncture, and no treatment. After 10 weeks, subjects in the acupuncture group showed an improvement in the apnea-hypopnea index and a reduction in the number of respiratory events compared with the sham-acupuncture group. The no-treatment group exhibited an increase in the number of respiratory events during the study (Freire 2007). More well-designed studies are needed to firmly establish the role of acupuncture in the treatment of sleep apnea.

Preliminary studies also suggest that auricular therapies, in which acupuncture points on the external ear are stimulated, may be helpful for people with sleep apnea, but more research is needed in this area (Wang 2009; Wang 2003; Wu 2012).

Smoking Cessation

Smokers have a higher risk of developing obstructive sleep apnea, and at a younger age, than non-smokers. Also, people who smoke more cigarettes for a longer time are at greater risk for more severe sleep apnea. It is thought that smoking-related airway inflammation and loss of pharyngeal muscle tone due to nicotine withdrawal during sleep may contribute to increased risk among smokers (Lin 2012; Hizli 2013; Quan 2014; Boussoffara 2013).

Alcohol and Sedative Avoidance

Alcohol is a central nervous system depressant that can contribute to obstructive sleep apnea (Scanlan 2000; Juntunen 1984). Like other sedatives, it can decrease respiratory center activity and weaken the drive to inhale (Motamedi 2009; St John 1986; Stein 2005). It may also cause weakness in the muscular structures of the pharynx, increasing the tendency for airway collapse, causing snoring and obstructive apnea. People with sleep apnea have also been found to be more susceptible to the effects of alcohol and may have a higher risk of alcohol-related automobile accidents compared to people without sleep apnea (Vakulin 2009).

Sleep Position

For some people, sleep position has a marked impact on severity of apneic and hypopneic breathing during sleep. Lying on one’s back (supine position) has been linked to greater severity of sleep apnea, but studies show that certain people are more likely to benefit from a position change. Individuals with positional sleep apnea tend to be thinner and younger, have a smaller neck circumference, and have milder sleep apnea. In some cases, adjusting sleep position is all that is required to satisfactorily relieve obstructive sleep apnea (Menon 2013).

Strategies for maintaining a non-supine position during sleep include using barriers such as firm pillows or other props like tennis balls sewn into the back of a shirt to prevent rolling onto the back (Skinner 2008). However, many patients find these methods uncomfortable and stop using them (Oksenberg 2006; Bignold 2009; Park 2011).

Allergy and Asthma Management

People with allergies and asthma have a higher risk of obstructive sleep apnea. Airway resistance and nasal congestion may contribute to this relationship (Braido 2014; Koinis-Mitchell 2012). One study found that treatment of obstructive sleep apnea with CPAP eliminated nighttime asthma (Salles 2013).

Low Sodium Diet

High levels of aldosterone, an adrenal hormone that regulates the concentration of sodium and potassium in the body, have been noted in people with sleep apnea and treatment-resistant hypertension (Calhoun 2004; Grossman 2014). One research group found that in people with obstructive sleep apnea who also have hypertension and hyperaldosteronism, urinary sodium level independently predicted severity of sleep apnea (Pimenta 2013). A similar study found that higher morning urinary sodium was linked to more severe obstructive sleep disordered breathing in children (Kaditis 2010). Since urinary sodium is generally a reflection of dietary sodium intake, and dietary sodium is related to obstructive sleep apnea severity in patients with resistant hypertension and hyperaldosteronism, dietary sodium restriction has been proposed as a treatment strategy for reduction of obstructive sleep apnea severity in such patients (Pimenta 2013; Grimes 2013; Cirillo 1997).

10 Integrative Interventions

In addition to the interventions described in this protocol, readers should also review the Life Extension protocols on Weight Loss, Cardiovascular Disease, Chronic Inflammation, and Diabetes, given the strong associations between sleep apnea and metabolic health. In addition, a number of strategies for improving sleep quality and sleep hygiene in general are described in the Insomnia protocol and may be of use for those with sleep apnea.

N-Acetyl Cysteine

Cysteine is an amino acid used by the body to synthesize the critical detoxification and antioxidant molecule glutathione; and N-acetyl cysteine (NAC) has mucus-reducing (mucolytic) properties (Tse 2014; Lu 2013). In a placebo-controlled, randomized trial in 20 adults with obstructive sleep apnea, 600 mg of NAC was given three times daily for 30 days. The NAC group experienced multiple significant improvements in measurements of apnea severity and sleep quality. NAC produced marked reductions in snoring and sleepiness compared with placebo. The NAC group showed significant reductions in oxidative stress as measured by lipid peroxidation and total reduced glutathione level (Sadasivam 2011). In an animal model of sleep apnea, supplementation with NAC mitigated oxidative stress and inflammation that occurred as a result of intermittent hypoxia (da Rosa 2015). 

Vitamin C

In a preliminary study, 10 people with obstructive sleep apnea were found to have dysfunction of the delicate lining of blood vessels (the endothelium) compared with 10 healthy controls. After a single 500 mg dose of intravenous vitamin C, endothelial function improved to a level comparable to that of the healthy subjects (Grebe 2006). In another study, a combination of 100 mg of vitamin C and 400 IU of vitamin E, taken by mouth twice daily for 45 days, led to reductions in apneic episodes and daytime sleepiness, and improved sleep quality, in obstructive sleep apnea patients being treated with CPAP. People taking the vitamin C and E combination were able to reduce pressure settings on their CPAP machines (Singh 2009).

Vitamin E

Individuals with obstructive sleep apnea have been reported to have low vitamin E levels (Barcelo 2006). As mentioned previously, combination vitamin E and C treatment was shown to benefit patients with obstructive sleep apnea (Singh 2009). Another study used a combination antioxidant treatment that included vitamin E in a comparison of breathing function in 13 healthy men and 13 men with obstructive sleep apnea. Both groups were exposed to intermittent hypoxia to mimic sleep apnea conditions, but before this exposure participants were randomly selected to receive pretreatment with either an antioxidant cocktail or placebo. The antioxidant treatment was an oral combination of 200 IU vitamin E, 60 mg coenzyme Q10, and 400 mg of the enzyme superoxide dismutase, given with yogurt, along with two intravenous doses of 1000 mg vitamin C. In the placebo group, both healthy controls and those with sleep apnea showed increased involuntary breathing effort, though that effort was significantly greater in the sleep apnea group. However, the men with obstructive sleep apnea who received the antioxidant treatment showed significantly better respiratory function compared with those receiving placebo treatment (Lee 2009).

Coenzyme Q10

Coenzyme Q10 (CoQ10) is involved in mitochondrial energy production and is best known for its beneficial effects on the heart and cardiovascular system (Garrido-Maraver 2014). As demonstrated in the study mentioned previously, CoQ10 in combination with other antioxidants favorably influenced respiratory function in men with obstructive sleep apnea (Lee 2009). It should be noted that patients with sleep apnea are at increased risk for cardiovascular disease, high blood pressure, and impaired glucose tolerance; and supplementation with CoQ10 may confer a benefit in all of these conditions (Kizaki 2014; Amin 2014; Garrido-Maraver 2014; Schmelzer 2008).


Selenium is an essential component and regulator of an enzyme called glutathione peroxidase, which is an important part of the body’s cellular oxidative stress defense systems (Rotruck 1973; Baker 1993). In a study of trace minerals in 44 individuals newly diagnosed with mild-to-moderate obstructive sleep apnea compared to 20 healthy controls, those with sleep apnea had lower levels of red blood cell selenium and glutathione peroxidase activity than people without apnea. There were significant differences in these measures between those with moderate compared to mild obstructive sleep apnea. The apnea-hypopnea index, the standard measurement of apnea and hypopnea severity, was higher in patients with lower red blood cell selenium (Chen 2013). One researcher reported on the case of his 70-year old wife whose mild obstructive sleep apnea was subjectively improved after taking 100 mcg of L-selenomethionine per day (Dekok 2005).

Vitamin D

Low vitamin D status has been linked to a wide array of common chronic conditions including heart disease, obesity, diabetes, autoimmune diseases, and some cancers (Grineva 2013; Basit 2013; Foss 2009); low vitamin D levels may also be associated with sleep apnea.

A study with 150 participants found vitamin D deficiency to be more pronounced in people with severe sleep apnea compared to those with mild-to-moderate sleep apnea (Mete 2013). This finding was corroborated in another study, in which the authors suggested that vitamin D supplementation be considered in obstructive sleep apnea patients for its role in normalizing glucose metabolism and inflammation (Bozkurt 2012).

As vitamin D level increases, parathyroid hormone level tends to decrease (Muscogiuri 2014). A study in 128 people found that vitamin D levels were lower and parathyroid hormone levels were higher in people with obstructive sleep apnea than in a control group without the condition (Erden 2014). In another study in 826 people with obstructive sleep apnea, those with insufficient vitamin D status were more likely to have diabetes and metabolic syndrome, and those with higher levels of parathyroid hormone were more likely to have hypertension and obesity (Barcelo 2013).

Maintaining healthy vitamin D status may also protect against a host of other chronic diseases, both related and unrelated to sleep apnea (Basit 2013; Muscogiuri 2014).  

Omega-3 Fatty Acids

Sufficient levels of the polyunsaturated omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been linked to lower degrees of systemic inflammation and lower risk of many chronic diseases, including those correlated with sleep apnea (Scorza 2013). A study that examined the red blood cell membrane fatty acid profiles of individuals with obstructive sleep apnea found that lower membrane DHA levels were associated with increased likelihood of severe sleep apnea. The authors suggest that red blood cell DHA testing could play a role in the diagnosis of obstructive sleep apnea, and further studies should investigate the effects of DHA supplementation in obstructive sleep apnea (Ladesich 2011).

B Vitamins

A number of studies have found that people with obstructive sleep apnea have higher levels of homocysteine, an amino acid linked to increased risk of cardiovascular and neurodegenerative diseases (Niu 2014; Monneret 2012; Sariman 2010; Ansari 2014; Jordan 2004).

High homocysteine levels may be more common in people with sleep apnea who also have hypertension, ischemic heart disease, or obesity; in those diagnosed with sleep apnea before age 50; and in those with more severe sleep apnea (Lavie 2001; Niu 2014). A rigorous analysis of six studies in a total of 206 participants concluded that CPAP could effectively lower high homocysteine levels in people with obstructive sleep apnea when they used the device for three months or more (Chen, Niu 2014).

Supplementation with the B vitamins folate, B6, and B12 can reduce serum homocysteine levels (Smach 2013) and may be effective in cardiovascular disease prevention (Debreceni 2014). Because of the close relationship between sleep apnea and heart disease, B vitamin supplementation may be important in people with sleep apnea. Importantly, evidence suggests supplementation with methylfolate, a metabolically active form of folate, may outperform folic acid supplementation for homocysteine reduction (Akoglu 2008; Venn 2003; Litynski 2002).

More information about the importance of keeping homocysteine levels low and strategies to do so are available in the Homocysteine Reduction protocol.

Disclaimer and Safety Information

This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a physician or other qualified health care professional. Pregnant women in particular should seek the advice of a physician before using any protocol listed on this website. The protocols described on this website are for adults only, unless otherwise specified. Product labels may contain important safety information and the most recent product information provided by the product manufacturers should be carefully reviewed prior to use to verify the dose, administration, and contraindications. National, state, and local laws may vary regarding the use and application of many of the therapies discussed. The reader assumes the risk of any injuries. The authors and publishers, their affiliates and assigns are not liable for any injury and/or damage to persons arising from this protocol and expressly disclaim responsibility for any adverse effects resulting from the use of the information contained herein.

The protocols raise many issues that are subject to change as new data emerge. None of our suggested protocol regimens can guarantee health benefits. Life Extension has not performed independent verification of the data contained in the referenced materials, and expressly disclaims responsibility for any error in the literature.

Adeseun GA, Rosas SE. The impact of obstructive sleep apnea on chronic kidney disease. Current hypertension reports. Oct 2010;12(5):378-383.

Aggarwal S, Nadeem R, Loomba RS, Nida M, Vieira D. The effects of continuous positive airways pressure therapy on cardiovascular end points in patients with sleep-disordered breathing and heart failure: a meta-analysis of randomized controlled trials. Clinical cardiology. Jan 2014;37(1):57-65.

AHA. American Heart Association. Resistant Hypertension. Available at: 10/30/2014. Accessed 1/21/2015.

Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr. Mar 2013;97(3):505-516.

Akoglu B, Schrott M, Bolouri H, Jaffari A, Kutschera E, Caspary WF, Faust D. The folic acid metabolite L-5-methyltetrahydrofolate effectively reduces total serum homocysteine level in orthotopic liver transplant recipients: a double-blind placebo-controlled study. European journal of clinical nutrition. Jun 2008;62(6):796-801.

Ali SS, Oni ET, Warraich HJ, Blaha MJ, Blumenthal RS, Karim A, . . . Nasir K. Systematic review on noninvasive assessment of subclinical cardiovascular disease in obstructive sleep apnea: new kid on the block! Sleep medicine reviews. Oct 2014;18(5):379-391.

Almeida FR, Mulgrew A, Ayas N, Tsuda H, Lowe AA, Fox N, . . . Fleetham JA. Mandibular advancement splint as short-term alternative treatment in patients with obstructive sleep apnea already effectively treated with continuous positive airway pressure. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. Apr 15 2013;9(4):319-324.

Alzoghaibi MA, Bahammam AS. The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea. Sleep & breathing = Schlaf & Atmung. Jun 2012;16(2):499-504.

Amin MM, Asaad GF, Abdel Salam RM, El-Abhar HS, Arbid MS. Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats. PloS one. 2014;9(2):e89169.

Andersen ML, Tufik S. The effects of testosterone on sleep and sleep-disordered breathing in men: its bidirectional interaction with erectile function. Sleep Med Rev. Oct 2008;12(5):365-379.

Ansari R, Mahta A, Mallack E, Luo JJ. Hyperhomocysteinemia and neurologic disorders: a review. J Clin Neurol. Oct 2014;10(4):281-288.

Araghi MH, Chen YF, Jagielski A, Choudhury S, Banerjee D, Hussain S, . . . Taheri S. Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis. Sleep. Oct 2013;36(10):1553-1562, 1562a-1562e.

ASAA. American Sleep Apnea Association. Central Sleep Apnea. Available at: Last updated 2014. Accessed 10/06/2014.

ATS. American Thoracic Society. Anatomy and Function of the Normal Lung. Available at: Accessed 12/19/2014.

Ayas NT, Hirsch AA, Laher I, Bradley TD, Malhotra A, Polotsky VY, Tasali E. New frontiers in obstructive sleep apnoea. Clinical science (London, England : 1979). Aug 2014;127(4):209-216.

Ayas NT, Mancini GB, Fleetham J. Does CPAP delay the development of cardiovascular disease in patients with obstructive sleep apnoea hypopnoea? Thorax. Jun 2006;61(6):459-460.

Badran M, Ayas N, Laher I. Cardiovascular complications of sleep apnea: role of oxidative stress. Oxid Med Cell Longev. 2014;2014:985258.

Baker RD, Baker SS, LaRosa K, Whitney C, Newburger PE. Selenium regulation of glutathione peroxidase in human hepatoma cell line Hep3B. Archives of biochemistry and biophysics. Jul 1993;304(1):53-57.

Ballard RD, Gay PC, Strollo PJ. Interventions to improve compliance in sleep apnea patients previously non-compliant with continuous positive airway pressure. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. Dec 15 2007;3(7):706-712.

Barcelo A, Barbe F, de la Pena M, Vila M, Perez G, Pierola J, . . . Agusti AG. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J. Apr 2006;27(4):756-760.

Barcelo A, Esquinas C, Pierola J, De la Pena M, Sanchez-de-la-Torre M, Montserrat JM, . . . Barbe F. Vitamin D status and parathyroid hormone levels in patients with obstructive sleep apnea. Respiration. 2013;86(4):295-301.

Barrett-Connor E, Dam TT, Stone K, et al. The association of testoserone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J Clin Endocrinol Metab. 2008;93(7):2602-9.

Basit S. Vitamin D in health and disease: a literature review. British journal of biomedical science. 2013;70(4):161-172.

Becker K. Medscape online. Drugs & Diseases page. Central Sleep Apnea Medication: Medication Summary. Available at: Last updated 9/15/2014. Accessed 12/31/2014.

Beecroft J, Zanon S, Lukic D, Hanly P. Oral continuous positive airway pressure for sleep apnea: effectiveness, patient preference, and adherence. Chest. Dec 2003;124(6):2200-2208.

Bercea R, Bercea B, Mihaescu T. [Association between the serum level of testosterone and other comorbidities in obstructive sleep apnea]. Pneumologia (Bucharest, Romania). Apr-Jun 2012;61(2):98-101.

Bercea RM, Mihaescu T, Cojocaru C, Bjorvatn B. Fatigue and serum testosterone in obstructive sleep apnea patients. The clinical respiratory journal. Apr 14 2014.

Bercea RM, Patacchioli FR, Ghiciuc CM, Cojocaru E, Mihaescu T. Serum testosterone and depressive symptoms in severe OSA patients. Andrologia. Oct 2013;45(5):345-350.

Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men wih androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010 Jun;95(6):2536-59. <>

Bignold JJ, Deans-Costi G, Goldsworthy MR, Robertson CA, McEvoy D, Catcheside PG, Mercer JD. Poor long-term patient compliance with the tennis ball technique for treating positional obstructive sleep apnea. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. Oct 15 2009;5(5):428-430.

Bilston LE, Gandevia SC. Biomechanical properties of the human upper airway and their effect on its behavior during breathing and in obstructive sleep apnea. Journal of applied physiology (Bethesda, Md. : 1985). Feb 1 2014;116(3):314-324.

Bittencourt LR, Lucchesi LM, Rueda AD, Garbuio SA, Palombini LO, Guilleminault C, Tufik S. Placebo and modafinil effect on sleepiness in obstructive sleep apnea. Progress in neuro-psychopharmacology & biological psychiatry. Feb 15 2008;32(2):552-559.

Black JE, Hirshkowitz M. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome. Sleep. Apr 2005;28(4):464-471.

Bo C, Zhang XS, Huang H, Jia Y, Xie XM. [A study on differences of curative effects of acupuncture and nCPAP for treatment of OSAHS]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion. Feb 2008;28(2):79-83.

Bohm M, Linz D, Urban D, Mahfoud F, Ukena C. Renal sympathetic denervation: applications in hypertension and beyond. Nature reviews. Cardiology. Aug 2013;10(8):465-476.

Bonsignore MR, Borel AL, Machan E, Grunstein R. Sleep apnoea and metabolic dysfunction. Eur Respir Rev. Sep 1 2013;22(129):353-364.

Boussoffara L, Boudawara N, Sakka M, Knani J. [Smoking habits and severity of obstructive sleep apnea hypopnea syndrome]. Revue des maladies respiratoires. Jan 2013;30(1):38-43.

Boyles S. Renal Denervation: Not Dead Yet? Available at: Last updated 12/10/2014. Accessed 3/13/2015.

Bozkurt NC, Cakal E, Sahin M, Ozkaya EC, Firat H, Delibasi T. The relation of serum 25-hydroxyvitamin-D levels with severity of obstructive sleep apnea and glucose metabolism abnormalities. Endocrine. Jun 2012;41(3):518-525.

Braido F, Baiardini I, Lacedonia D, Facchini FM, Fanfulla F, Molinengo G, Canonica GW. Sleep Apnea Risk in Patients With Asthma With or Without Comorbid Rhinitis. Respiratory care. Jun 10 2014.

Buratti L, Viticchi G, Falsetti L, Cagnetti C, Luzzi S, Bartolini M, . . . Silvestrini M. Vascular impairment in Alzheimer's disease: the role of obstructive sleep apnea. J Alzheimers Dis. 2014;38(2):445-453.

Calaora-Tournadre D, Ragot S, Meurice JC, Pourrat O, D'Halluin G, Magnin G, Pierre F. [Obstructive Sleep Apnea Syndrom during pregnancy: prevalence of main symptoms and relationship with Pregnancy Induced-Hypertension and Intra-Uterine Growth Retardation]. La Revue de medecine interne / fondee ... par la Societe nationale francaise de medecine interne. Apr 2006;27(4):291-295.

Calhoun DA, Nishizaka MK, Zaman MA, Harding SM. Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest. Jan 2004;125(1):112-117.

Camacho M, Certal V, Capasso R. Comprehensive review of surgeries for obstructive sleep apnea syndrome. Brazilian journal of otorhinolaryngology. Nov-Dec 2013;79(6):780-788.

Canales MT, Liu LY, Taylor BC, et al. Renal function and sleep-disordered breathing in older men. Nephrol Dial Transplant. 2008;23(12):3908-14.

Canguven O, Salepci B, Albayrak S, Selimoglu A, Balaban M, Bulbul M. Is there a correlation between testosterone levels and the severity of the disease in male patients with obstructive sleep apnea? Archivio italiano di urologia, andrologia: organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica / Associazione ricerche in urologia. Dec 2010;82(4):143-147.

Cantalejo Moreira M, Veiga Cabello RM, Garcia Diaz V, Racionero Casero MA, Zapatero Gaviria A. Gout, hyperuricaemia, sleep apnoea-hypopnoea syndrome and vascular risk. Rheumatology (Oxford). Sep 2013;52(9):1619-1622.

Chan AS, Lee RW, Cistulli PA. Dental appliance treatment for obstructive sleep apnea. Chest. Aug 2007;132(2):693-699.

Chen L, Pei JH, Chen HM. Effects of continuous positive airway pressure treatment on glycaemic control and insulin sensitivity in patients with obstructive sleep apnoea and type 2 diabetes: a meta-analysis. Arch Med Sci. Aug 29 2014;10(4):637-642.

Chen PC, Guo CH, Tseng CJ, Wang KC, Liu PJ. Blood trace minerals concentrations and oxidative stress in patients with obstructive sleep apnea. The journal of nutrition, health & aging. 2013;17(8):639-644.

Chen X, Niu X, Xiao Y, Dong J, Zhang R, Lu M, Kong W. Effect of continuous positive airway pressure on homocysteine levels in patients with obstructive sleep apnea: a meta-analysis. Sleep & breathing = Schlaf & Atmung. Jan 26 2014.

Chiner E, Andreu AL, Sancho-Chust JN, Sanchez-de-la-Torre A, Barbe F. The use of ambulatory strategies for the diagnosis and treatment of obstructive sleep apnea in adults. Expert review of respiratory medicine. Jun 2013;7(3):259-273.

Chirakalwasan N, Teerapraipruk B, Simon R, Hirunwiwatkul P, Jaimchariyatam N, Desudchit T, . . . Wanlapakorn C. Comparison of polysomnographic and clinical presentations and predictors for cardiovascular-related diseases between non-obese and obese obstructive sleep apnea among Asians. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2013;9(6):553-557.

Chou YT, Lee PH, Yang CT, Lin CL, Veasey S, Chuang LP, . . . Chen NH. Obstructive sleep apnea: a stand-alone risk factor for chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association. Jul 2011;26(7):2244-2250.

Chung F, Subramanyam R, Liao P, Sasaki E, Shapiro C, Sun Y. High STOP-Bang score indicates a high probability of obstructive sleep apnoea. British journal of anaesthesia. May 2012;108(5):768-775.

Chung F, Yang Y, Liao P. Predictive performance of the STOP-Bang score for identifying obstructive sleep apnea in obese patients. Obesity surgery. Dec 2013;23(12):2050-2057.

Chung SD, Lin CC, Liu SP, Lin HC. Obstructive sleep apnea increases the risk of bladder pain syndrome/interstitial cystitis: a population-based matched-cohort study. Neurourology and urodynamics. Mar 2014;33(3):278-282.

Cirillo M, Ciacci C, Laurénzi M, et al. Salt intake, urinary sodium, and hypercalciuria. Miner Electrolyte Metab. 1997;23(3-6):265-8.

Colrain IM, Black J, Siegel LC, Bogan RK, Becker PM, Farid-Moayer M, . . . Malhotra A. A multicenter evaluation of oral pressure therapy for the treatment of obstructive sleep apnea. Sleep Med. Sep 2013;14(9):830-837.

Cordero-Guevara J, Teran-Santos J, Luz Alonso-Alvarez M, Castrodeza-Sanz J, Ordax-Carbajo E, Masa-Jimenez F. Effectiveness of Nasal Continuous Positive Airway Pressure (CPAP) Therapy on Cardiovascular Outcomes in Obstructive Sleep Apnea-Hypopnea Syndrome (OSAHS). Current Respiratory Medicine Reviews. 2011;7(2):121-129.

Cross RL, Kumar R, Macey PM, Doering LV, Alger JR, Yan-Go FL, Harper RM. Neural alterations and depressive symptoms in obstructive sleep apnea patients. Sleep. Aug 2008;31(8):1103-1109.

da Rosa DP, Forgiarini LF, e Silva MB, Fiori CZ, Andrade CF, Martinez D, Marroni NP. Antioxidants inhibit the inflammatory and apoptotic processes in an intermittent hypoxia model of sleep apnea. Inflammation research: official journal of the European Histamine Research Society ... [et al.]. Jan 2015;64(1):21-29.

Dancey DR, Hanly PJ, Soong C, Lee B, Hoffstein V. Impact of menopause on the prevalence and severity of sleep apnea. Chest. Jul 2001;120(1):151-155.

Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature reviews. Neuroscience. Jan 2008;9(1):46-56.

De Backer W. Obstructive sleep apnea/hypopnea syndrome. Panminerva medica. Jun 2013;55(2):191-195.

De Dios JA, Brass SD. New and unconventional treatments for obstructive sleep apnea. Neurotherapeutics. Oct 2012;9(4):702-709.

Debreceni B, Debreceni L. The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease. Cardiovascular therapeutics. Jun 2014;32(3):130-138.

Dekok HJ. Case report: the medical treatment of obstructive sleep apnoea syndrome (OSAS) with Selenium. Med Hypotheses. 2005;65(4):817-818.

Domenech M, Roman P, Lapetra J, Garcia de la Corte FJ, Sala-Vila A, de la Torre R, . . . Ros E. Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids: one-year randomized, clinical trial. Hypertension. Jul 2014;64(1):69-76.

Dopp JM, Morgan BJ. Pharmacologic approaches for the management of symptoms and cardiovascular consequences of obstructive sleep apnea in adults. Sleep & breathing = Schlaf & Atmung. Dec 2010;14(4):307-315.

Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. Aug 13 2013;62(7):569-576.

Dursunoglu N. Effects of menopause on obstructive sleep apnea. Tuberkuloz ve toraks. 2009;57(1):109-114.

Dusek JA, Benson H. Mind-body medicine: a model of the comparative clinical impact of the acute stress and relaxation responses. Minnesota medicine. May 2009;92(5):47-50.

Eastwood PR, Barnes M, Walsh JH, Maddison KJ, Hee G, Schwartz AR, . . . Hillman DR. Treating obstructive sleep apnea with hypoglossal nerve stimulation. Sleep. Nov 2011;34(11):1479-1486.

Eckert DJ, Younes MK. Arousal from sleep: implications for obstructive sleep apnea pathogenesis and treatment. Journal of applied physiology (Bethesda, Md. : 1985). Feb 1 2014;116(3):302-313.

Ehrmann DA. Metabolic dysfunction in pcos: Relationship to obstructive sleep apnea. Steroids. Mar 10 2012;77(4):290-294.

Ellen RL, Marshall SC, Palayew M, Molnar FJ, Wilson KG, Man-Son-Hing M. Systematic review of motor vehicle crash risk in persons with sleep apnea. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. Apr 15 2006;2(2):193-200.

Elshaug AG, Moss JR, Hiller JE, Maddern GJ. Upper airway surgery should not be first line treatment for obstructive sleep apnoea in adults. BMJ (Clinical research ed.). Jan 5 2008;336(7634):44-45.

Engleman HM, Cheshire KE, Deary IJ, Douglas NJ. Daytime sleepiness, cognitive performance and mood after continuous positive airway pressure for the sleep apnoea/hypopnoea syndrome. Thorax. Sep 1993;48(9):911-914.

Erden ES, Genc S, Motor S, Ustun I, Ulutas KT, Bilgic HK, . . . Gokce C. Investigation of serum bisphenol A, vitamin D, and parathyroid hormone levels in patients with obstructive sleep apnea syndrome. Endocrine. Mar 2014;45(2):311-318.

Esposito K, Giugliano D. Mediterranean diet and type 2 diabetes. Diabetes/metabolism research and reviews. Mar 2014;30 Suppl 1:34-40.

Estruch R, Ros E, Martinez-Gonzalez MA. Mediterranean diet for primary prevention of cardiovascular disease. N Engl J Med. Aug 15 2013;369(7):676-677.

Facco FL, Ouyang DW, Zee PC, Grobman WA. Development of a pregnancy-specific screening tool for sleep apnea. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2012;8(4):389-394.

Fava C, Dorigoni S, Dalle Vedove F, Danese E, Montagnana M, Guidi GC, . . . Minuz P. Effect of CPAP on blood pressure in patients with OSA/hypopnea a systematic review and meta-analysis. Chest. Apr 2014;145(4):762-771.

Ferini-Strambi L, Baietto C, Di Gioia MR, Castaldi P, Castronovo C, Zucconi M, Cappa SF. Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP). Brain research bulletin. Jun 30 2003;61(1):87-92.

Filomeno M, Bosetti C, Garavello W, Levi F, Galeone C, Negri E, La Vecchia C. The role of a Mediterranean diet on the risk of oral and pharyngeal cancer. British journal of cancer. Aug 26 2014;111(5):981-986.

Findley LJ, Weiss JW, Jabour ER. Drivers with untreated sleep apnea. A cause of death and serious injury. Archives of internal medicine. Jul 1991;151(7):1451-1452.

Floras JS. Sleep apnea and cardiovascular risk. Journal of cardiology. Jan 2014;63(1):3-8.

Foss YJ. Vitamin D deficiency is the cause of common obesity. Medical hypotheses. Mar 2009;72(3):314-321.

Freedman N. Improvements in current treatments and emerging therapies for adult obstructive sleep apnea. F1000Prime Rep. 2014;6:36.

Freire AO, Sugai GC, Chrispin FS, Togeiro SM, Yamamura Y, Mello LE, Tufik S. Treatment of moderate obstructive sleep apnea syndrome with acupuncture: a randomised, placebo-controlled pilot trial. Sleep medicine. Jan 2007;8(1):43-50.

Freire AO, Sugai GC, Togeiro SM, Mello LE, Tufik S. Immediate effect of acupuncture on the sleep pattern of patients with obstructive sleep apnoea. Acupuncture in medicine: journal of the British Medical Acupuncture Society. Sep 2010;28(3):115-119.

Gallegos L, Dharia T, Gadegbeku AB. Effect of continuous positive airway pressure on type 2 diabetes mellitus and glucose metabolism. Hospital practice (1995). Apr 2014;42(2):31-37.

Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Fernandez Vega A, de la Mata M, Delgado Pavon A, . . . Sanchez-Alcazar JA. Coenzyme q10 therapy. Molecular syndromology. Jul 2014;5(3-4):187-197.

Ge X, Han F, Huang Y, Zhang Y, Yang T, Bai C, Guo X. Is obstructive sleep apnea associated with cardiovascular and all-cause mortality? PLoS One. 2013;8(7):e69432.

Giebelhaus V, Strohl KP, Lormes W, Lehmann M, Netzer N. Physical Exercise as an Adjunct Therapy in Sleep Apnea-An Open Trial. Sleep & breathing = Schlaf & Atmung. 2000;4(4):173-176.

Gilliam EE, Goldberg SJ. Contractile properties of the tongue muscles: effects of hypoglossal nerve and extracellular motoneuron stimulation in rat. Journal of neurophysiology. Aug 1995;74(2):547-555.

Gillig PM, Sanders RD. Cranial Nerves IX, X, XI, and XII. Psychiatry (Edgmont (Pa. : Township)). May 2010;7(5):37-41.

Gottlieb DJ, Craig SE, Lorenzi-Filho G, Heeley E, Redline S, McEvoy RD, Duran-Cantolla J. Sleep Apnea Cardiovascular Clinical Trials-Current Status and Steps Forward: The International Collaboration of Sleep Apnea Cardiovascular Trialists. Sleep. 2013;36(7):975-980.

Gottlieb DJ, Punjabi NM, Mehra R, Patel SR, Quan SF, Babineau DC, . . . Redline S. CPAP versus oxygen in obstructive sleep apnea. The New England journal of medicine. Jun 12 2014;370(24):2276-2285.

Grebe M, Eisele HJ, Weissmann N, Schaefer C, Tillmanns H, Seeger W, Schulz R. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med. Apr 15 2006;173(8):897-901.

Grech A, Breck J, Heidelbaugh J. Adverse effects of testosterone replacement therapy: an update on the evidence and controversy. Therapeutic advances in drug safety. Oct 2014;5(5):190-200.

Grimes CA, Riddell LJ, Campbell KJ, Nowson CA. Dietary salt intake assessed by 24 h urinary sodium excretion in Australian schoolchildren aged 5-13 years. Public health nutrition. Oct 2013;16(10):1789-1795.

Grineva EN, Karonova T, Micheeva E, Belyaeva O, Nikitina IL. Vitamin D deficiency is a risk factor for obesity and diabetes type 2 in women at late reproductive age. Aging. Jul 2013;5(7):575-581.

Grossman AB. The Merck Manual online. Hyperaldosteronism. Available at: Last updated 9/2014. Accessed 1/22/2015. 2014.

Gutierrez C, Brady P. Obstructive sleep apnea: a diagnostic and treatment guide. J Fam Pract. Oct 2013;62(10):565-572.

Guyton AC. Textbook of Medical Physiology – 8th edition. Chemical Control of Respiration. pp. 446-449. Copyright 1990 by W.B. Saunders Co.

Hanafy HM. Testosterone therapy and obstructive sleep apnea: is there a real connection? The journal of sexual medicine. Sep 2007;4(5):1241-1246.

Handler E, Hamans E, Goldberg AN, Mickelson S. Tongue suspension: an evidence-based review and comparison to hypopharyngeal surgery for OSA. Laryngoscope. Jan 2014;124(1):329-336.

Hassaballa HA, Tulaimat A, Herdegen JJ, Mokhlesi B. The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea. Sleep & breathing = Schlaf & Atmung. Dec 2005;9(4):176-180.

Hayes DJ. Ferri's Clinical Advisor. Sleep Apnea, Obstructive. Available at: Copyright © 2014. Accessed 11/25/2014.

Hirotsu C, Tufik S, Guindalini C, Mazzotti DR, Bittencourt LR, Andersen ML. Association between uric acid levels and obstructive sleep apnea syndrome in a large epidemiological sample. PLoS One. 2013;8(6):e66891.

Hizli O, Ozcan M, Unal A. Evaluation of comorbidities in patients with OSAS and simple snoring. ScientificWorldJournal. 2013;2013:709292.

Ho ML, Brass SD. Obstructive sleep apnea. Neurology international. Nov 29 2011;3(3):e15.

Hoffman M, Schulman DA. The appearance of central sleep apnea after treatment of obstructive sleep apnea. Chest. Aug 2012;142(2):517-522.

Hoffstein V, Mateika S. Differences in abdominal and neck circumferences in patients with and without obstructive sleep apnoea. The European respiratory journal. Apr 1992;5(4):377-381.

Hoffstein V. Review of oral appliances for treatment of sleep-disordered breathing. Sleep & breathing = Schlaf & Atmung. Mar 2007;11(1):1-22.

Hohl M, Linz B, Bohm M, Linz D. Obstructive sleep apnea and atrial arrhythmogenesis. Current cardiology reviews. Nov 2014;10(4):362-368.

Hou YX, Jia SS, Liu YH. 17beta-Estradiol accentuates contractility of rat genioglossal muscle via regulation of estrogen receptor alpha. Archives of oral biology. Apr 2010;55(4):309-317.

Hoyos CM, Killick R, Yee BJ, Grunstein RR, Liu PY. Effects of testosterone therapy on sleep and breathing in obese men with severe obstructive sleep apnoea: a randomized placebo-controlled trial. Clinical endocrinology. Oct 2012;77(4):599-607.

Hoyos CM, Melehan KL, Liu PY, Grunstein RR, Phillips CL. Does obstructive sleep apnea cause endothelial dysfunction? A critical review of the literature. Sleep medicine reviews. Jun 25 2014.

Hoyos CM, Melehan KL, Phillips CL, Grunstein RR, Liu PY. To ED or not to ED - Is erectile dysfunction in obstructive sleep apnea related to endothelial dysfunction? Sleep medicine reviews. Mar 18 2014.

Hoyos CM, Yee BJ, Phillips CL, Machan EA, Grunstein RR, Liu PY. Body compositional and cardiometabolic effects of testosterone therapy in obese men with severe obstructive sleep apnoea: a randomised placebo-controlled trial. Eur J Endocrinol. Oct 2012;167(4):531-541.

Huang J, Sahin M, Noormahammad C, Durand DM. Activation patterns of the tongue muscles with selective stimulation of the hypoglossal nerve. Conference proceedings: ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference. 2004;6:4275-4278.

Iftikhar IH, Kline CE, Youngstedt SD. Effects of exercise training on sleep apnea: a meta-analysis. Lung. Feb 2014;192(1):175-184.

Inoue Y, Takasaki Y, Yamashiro Y. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. 2013;9(8):751-757.

Javaheri S, Dempsey JA. Central sleep apnea. Comprehensive Physiology. Jan 2013;3(1):141-163.

Jean-Louis G, Zizi F, Clark LT, Brown CD, McFarlane SI. Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. Jun 15 2008;4(3):261-272.

Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. Feb 22 2014;383(9918):736-747.

Jordan W, Berger C, Cohrs S, Rodenbeck A, Mayer G, Niedmann PD, . . . Bleich S. CPAP-therapy effectively lowers serum homocysteine in obstructive sleep apnea syndrome. Journal of neural transmission (Vienna, Austria: 1996). Jun 2004;111(6):683-689.

Juntunen J. Alcohol, work and the nervous system. Scandinavian journal of work, environment & health. Dec 1984;10(6 Spec No):461-465.

Kaditis AG, Alexopoulos EI, Evangelopoulos K, Kostadima E, Varlami V, Boultadakis E, . . . Gourgoulianis K. Correlation of urinary excretion of sodium with severity of sleep-disordered breathing in children: a preliminary study. Pediatric pulmonology. Oct 2010;45(10):999-1004.

Kanbay A, Inonu H, Solak Y, Erden A, Uslu E, Yuksel SA, . . . Kanbay M. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome. Eur J Intern Med. Jun 2014;25(5):471-476.

Kang JH, Lin HC. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Med. Jun 2012;13(6):583-588.

Kannan A, Medina RI, Nagajothi N, Balamuthusamy S. Renal sympathetic nervous system and the effects of denervation on renal arteries. World J Cardiol. Aug 26 2014;6(8):814-823.

Karacan I, Karatas M. Erectile dysfunction in sleep apnea and response to CPAP. J Sex Marital Ther. 1995;21(4):239-47.

Keefe DL, Watson R, Naftolin F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause (New York, N.Y.). Fall 1999;6(3):196-200.

Kendzerska T, Leung RS, Hawker G, Tomlinson G, Gershon AS. Obstructive sleep apnea and the prevalence and incidence of cancer. CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne. Sep 16 2014;186(13):985-992.

Kezirian EJ, Goding GS, Jr., Malhotra A, O'Donoghue FJ, Zammit G, Wheatley JR, . . . Barnes M. Hypoglossal nerve stimulation improves obstructive sleep apnea: 12-month outcomes. J Sleep Res. Feb 2014;23(1):77-83.

Khan MT, Franco RA. Complex sleep apnea syndrome. Sleep Disord. 2014;2014:798487.

Khatri M, Moon YP, Scarmeas N, Gu Y, Gardener H, Cheung K, . . . Elkind MS. The association between a Mediterranean-style diet and kidney function in the Northern Manhattan Study cohort. Clinical journal of the American Society of Nephrology: CJASN. Nov 7 2014;9(11):1868-1875.

Khirani S, Leboulanger N, Ramirez A, Fauroux B. Life-threatening obstructive sleep apnea caused by adenoid hypertrophy in an infant with noonan syndrome. Case reports in pediatrics. 2012;2012:514514.

Kielb SA, Ancoli-Israel S, Rebok GW, Spira AP. Cognition in obstructive sleep apnea-hypopnea syndrome (OSAS): current clinical knowledge and the impact of treatment. Neuromolecular Med. Sep 2012;14(3):180-193.

Killick R, Wang D, Hoyos CM, Yee BJ, Grunstein RR, Liu PY. The effects of testosterone on ventilatory responses in men with obstructive sleep apnea: a randomised, placebo-controlled trial. J Sleep Res. Jun 2013;22(3):331-336.

Kizaki K, Terada T, Arikawa H, Tajima T, Imai H, Takahashi T, Era S. Effect of reduced coenzyme Q10 (ubiquinol) supplementation on blood pressure and muscle damage during kendo training camp: a double-blind, randomized controlled study. The Journal of sports medicine and physical fitness. Nov 4 2014.

Kline CE, Ewing GB, Burch JB, Blair SN, Durstine JL, Davis JM, Youngstedt SD. Exercise training improves selected aspects of daytime functioning in adults with obstructive sleep apnea. J Clin Sleep Med. 2012;8(4):357-365.

Knapp A, Myhill PC, Davis WA, Peters KE, Hillman D, Hamilton EJ, . . . Davis TM. Effect of continuous positive airway pressure therapy on sexual function and serum testosterone in males with type 2 diabetes and obstructive sleep apnoea. Clinical endocrinology. Aug 2014;81(2):254-258.

Koinis-Mitchell D, Craig T, Esteban CA, Klein RB. Sleep and allergic disease: a summary of the literature and future directions for research. The Journal of allergy and clinical immunology. Dec 2012;130(6):1275-1281.

Kotecha BT, Hall AC. Role of surgery in adult obstructive sleep apnoea. Sleep medicine reviews. Oct 2014;18(5):405-413.

Kushida CA, Nichols DA, Holmes TH, Quan SF, Walsh JK, Gottlieb DJ, . . . Dement WC. Effects of continuous positive airway pressure on neurocognitive function in obstructive sleep apnea patients: The Apnea Positive Pressure Long-term Efficacy Study (APPLES). Sleep. Dec 2012;35(12):1593-1602.

Kwon CS, Loke YK, Pradhan S, et al. Renal denervation and blood pressure reduction in resistant hypertension: a sytematic review and meta-analysis. Open Heart. 2014;1(1):e000092.

Ladesich JB, Pottala JV, Romaker A, Harris WS. Membrane level of omega-3 docosahexaenoic acid is associated with severity of obstructive sleep apnea. J Clin Sleep Med. Aug 15 2011;7(4):391-396.

Lal C, Strange C, Bachman D. Neurocognitive impairment in obstructive sleep apnea. Chest. Jun 2012;141(6):1601-1610.

Lau EY, Eskes GA, Morrison DL, Rajda M, Spurr KF. The role of daytime sleepiness in psychosocial outcomes after treatment for obstructive sleep apnea. Sleep disorders. 2013;2013:140725.

Launois SH, Tamisier R, Levy P, Pepin JL. On treatment but still sleepy: cause and management of residual sleepiness in obstructive sleep apnea. Current opinion in pulmonary medicine. Nov 2013;19(6):601-608.

Lavie L, Perelman A, Lavie P. Plasma homocysteine levels in obstructive sleep apnea: association with cardiovascular morbidity. Chest. Sep 2001;120(3):900-908.

Lee DS, Badr MS, Mateika JH. Progressive augmentation and ventilatory long-term facilitation are enhanced in sleep apnoea patients and are mitigated by antioxidant administration. J Physiol. Nov 15 2009;587(Pt 22):5451-5467.

Lefcourt LA, Rodis JF. Obstructive sleep apnea in pregnancy. Obstetrical & gynecological survey. Aug 1996;51(8):503-506.

Lehman S, Antic NA, Thompson C, Catcheside PG, Mercer J, McEvoy RD. Central sleep apnea on commencement of continuous positive airway pressure in patients with a primary diagnosis of obstructive sleep apnea-hypopnea. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. Aug 15 2007;3(5):462-466.

Li HY, Lee LA, Wang PC, Chen NH, Lin Y, Fang TJ. Nasal surgery for snoring in patients with obstructive sleep apnea. The Laryngoscope. Feb 2008;118(2):354-359.

Lim YH, Choi J, Kim KR, Shin J, Hwang KG, Ryu S, Cho SH. Sex-specific characteristics of anthropometry in patients with obstructive sleep apnea: neck circumference and waist-hip ratio. The Annals of otology, rhinology, and laryngology. Jul 2014;123(7):517-523.

Lin PW, Friedman M, Lin HC, Chang HW, Wilson M, Lin MC. Normal tension glaucoma in patients with obstructive sleep apnea/hypopnea syndrome. Journal of glaucoma. Dec 2011;20(9):553-558.

Lin YN, Li QY, Zhang XJ. Interaction between smoking and obstructive sleep apnea: not just participants. Chinese medical journal. Sep 2012;125(17):3150-3156.

Litynski P, Loehrer F, Linder L, Todesco L, Fowler B. Effect of low doses of 5-methyltetrahydrofolate and folic acid on plasma homocysteine in healthy subjects with or without the 677C-->T polymorphism of methylenetetrahydrofolate reductase. European journal of clinical investigation. Sep 2002;32(9):662-668.

Liu YH, Huang Y, Shao X. Effects of estrogen on genioglossal muscle contractile properties and fiber-type distribution in chronic intermittent hypoxia rats. European journal of oral sciences. Dec 2009;117(6):685-690.

Lourida I, Soni M, Thompson-Coon J, Purandare N, Lang IA, Ukoumunne OC, Llewellyn DJ. Mediterranean diet, cognitive function, and dementia: a systematic review. Epidemiology (Cambridge, Mass.). Jul 2013;24(4):479-489.

Lu SC. Glutathione synthesis. Biochimica et biophysica acta. May 2013;1830(5):3143-3153.

Lucey BP, Bateman RJ. Amyloid-beta diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis. Neurobiol Aging. Sep 2014;35 Suppl 2:S29-34.

Mahfoud F, Kjeldsen SE. Catheter-based renal denervation: a world of caution. Available at: Copyright 2013. Accessed 3/13/2015.

Manber R, Kuo TF, Cataldo N, Colrain IM. The effects of hormone replacement therapy on sleep-disordered breathing in postmenopausal women: a pilot study. Sleep. Mar 15 2003;26(2):163-168.

Mandrola J. Medscape. News & Prespective page. Five Lessons to Be Learned From the Fall of Renal Denervation. Available at: 1/14/2014. Accessed 3/13/2015.

Marin JM, Carrizo SJ, Vincente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. The Lancet. 2005;365(9464):1046-53.

Marshall NS, Wong KK, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea and 20-year follow-up for all-cause mortality, stroke, and cancer incidence and mortality in the busselton health study cohort. J Clin Sleep Med. Apr 15 2014;10(4):355-362.

Martinez Ceron E, Casitas Mateos R, Garcia-Rio F. Sleep Apnea-Hypopnea Syndrome and Type 2 Diabetes. A Reciprocal Relationship? Archivos de bronconeumologia. Aug 18 2014.

Martinez Ceron E, Casitas Mateos R, Garcia-Rio F. Sleep Apnea-Hypopnea Syndrome and Type 2 Diabetes. A Reciprocal Relationship? Archivos de bronconeumologia. Mar 2015;51(3):128-139.

Mason M, Welsh EJ, Smith I. Drug therapy for obstructive sleep apnoea in adults. Cochrane Database Syst Rev. 2013;5:Cd003002.

Matsumoto AM, Sandblom RE, Schoene RB, Lee KA, Giblin EC, Pierson DJ, Bremner WJ. Testosterone replacement in hypogonadal men: effects on obstructive sleep apnoea, respiratory drives, and sleep. Clinical endocrinology. Jun 1985;22(6):713-721.

Mayo Clinic. Diseases and Conditions page. Central sleep apnea: Treatments and drugs. Available at: 6/28/2013. Accessed 12/31/2014.

Mayo Clinic. Diseases and Conditions: Sleep Apnea. Available at: Last updated 07/24/2012. Accessed 10/10/14.

Menon A, Kumar M. Influence of body position on severity of obstructive sleep apnea: a systematic review. ISRN Otolaryngol. 2013;2013:670381.

Mete T, Yalcin Y, Berker D, Ciftci B, Guven SF, Topaloglu O, . . . Guler S. Obstructive sleep apnea syndrome and its association with vitamin D deficiency. Journal of endocrinological investigation. Oct 2013;36(9):681-685.

Mirrakhimov AE. Obstructive sleep apnea and autoimmune rheumatic disease: is there any link? Inflammation & allergy drug targets. Oct 2013;12(5):362-367.

Mitchell LJ, Davidson ZE, Bonham M, O'Driscoll DM, Hamilton GS, Truby H. Weight loss from lifestyle interventions and severity of sleep apnoea: a systematic review and meta-analysis. Sleep Med. Oct 2014;15(10):1173-1183.

Monahan K, Redline S. Role of obstructive sleep apnea in cardiovascular disease. Current opinion in cardiology. Nov 2011;26(6):541-547.

Monneret D, Tamisier R, Ducros V, Garrel C, Levy P, Baguet JP, . . . Pepin JL. The impact of obstructive sleep apnea on homocysteine and carotid remodeling in metabolic syndrome. Respiratory physiology & neurobiology. Mar 15 2012;180(2-3):298-304.

Motamedi KK, McClary AC, Amedee RG. Obstructive sleep apnea: a growing problem. The Ochsner journal. Fall 2009;9(3):149-153.

Muscogiuri G, Mitri J, Mathieu C, Badenhoop K, Tamer G, Orio F, . . . Pittas A. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. European journal of endocrinology / European Federation of Endocrine Societies. Sep 2014;171(3):R101-110.

Mwenge GB, Rombaux P, Dury M, Lengele B, Rodenstein D. Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study. Eur Respir J. Feb 2013;41(2):360-367.

Nadeem R, Molnar J, Madbouly EM, Nida M, Aggarwal S, Sajid H, . . . Loomba R. Serum inflammatory markers in obstructive sleep apnea: a meta-analysis. J Clin Sleep Med. Oct 15 2013;9(10):1003-1012.

Nannapaneni S, Ramar K, Surani S. Effect of obstructive sleep apnea on type 2 diabetes mellitus: A comprehensive literature review. World J Diabetes. Dec 15 2013;4(6):238-244.

Nattie E. CO2, brainstem chemoreceptors and breathing. Progress in neurobiology. Nov 1999;59(4):299-331.

Netzer NC, Eliasson AH, Strohl KP. Women with sleep apnea have lower levels of sex hormones. Sleep & breathing = Schlaf & Atmung. Mar 2003;7(1):25-29.

NIDDK. National Institute of Diabetes and Digestive and Kidney Kidney Diseases. Gestational Diabetes: What You Need to Know. Available at: Last updated 10/2/2013. Accessed 1/19/2015.

Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farre R. Sleep-disordered breathing and cancer mortality: results from the Wisconsin Sleep Cohort Study. American journal of respiratory and critical care medicine. Jul 15 2012;186(2):190-194.

NIH. National Institutes of Health. Institute of Medicine (US) Committee on Sleep Medicine and Research; Colten HR, Altevogt BM, eds. Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem. Chapter 4: Functional and Economic Impact of Sleep Loss and Sleep-Related Disrders. Available at: National Academies Press (US); 2006.

Niu X, Chen X, Xiao Y, Dong J, Zhang R, Lu M, Kong W. The differences in homocysteine level between obstructive sleep apnea patients and controls: a meta-analysis. PloS one. 2014;9(4):e95794.

NLM. U.S. National Library of Medicine. Health Topics page. Diabetes and Pregnancy. Available at: Last updated 2/6/2015b. Accessed 1/19/2015.

NLM. U.S. National Library of Medicine. Health Topics page. Gout. Available at: Last updated 12/12/2014. Accessed 1/19/2015.

NLM. U.S. National Library of Medicine. PubMed Health. Modafinil (Oral route). Available at: 2/1/2015a. Accessed 3/3/2015.

Noguti J, Andersen ML, Cirelli C, Ribeiro DA. Oxidative stress, cancer, and sleep deprivation: is there a logical link in this association? Sleep & breathing = Schlaf & Atmung. Sep 2013;17(3):905-910.

NSF. National Sleep Foundation. Sleep Apnea. Available at: Last updated 2014. Accessed 10/05/2014.

Oksenberg A, Silverberg D, Offenbach D, Arons E. Positional therapy for obstructive sleep apnea patients: A 6-month follow-up study. The Laryngoscope. Nov 2006;116(11):1995-2000.

Oldenburg O, Bitter T, Fox H, Horstkotte D. [Sleep-related breathing disorders and (resulting) cardiovascular diseases]. Herz. Feb 2014;39(1):37-44.

Oliven A. Treating obstructive sleep apnea with hypoglossal nerve stimulation. Current opinion in pulmonary medicine. Nov 2011;17(6):419-424.

OPT. Oldways Preservation Trust. Mediterranian Diet Pyramid. Available at: Accessed 2/18/2015.

Paiva T, Attarian H. Obstructive sleep apnea and other sleep-related syndromes. Handbook of clinical neurology. 2014;119:251-271.

Pamidi S, Pinto LM, Marc I, Benedetti A, Schwartzman K, Kimoff RJ. Maternal sleep-disordered breathing and adverse pregnancy outcomes: a systematic review and metaanalysis. Am J Obstet Gynecol. Jan 2014;210(1):52.e51-52.e14.

Panossian L, Daley J. Sleep-disordered breathing. Continuum (Minneapolis, Minn.). Feb 2013;19(1 Sleep Disorders):86-103.

Papandreou C, Schiza SE, Bouloukaki I, Hatzis CM, Kafatos AG, Siafakas NM, Tzanakis NE. Effect of Mediterranean diet versus prudent diet combined with physical activity on OSAS: a randomised trial. Eur Respir J. Jun 2012;39(6):1398-1404.

Parati G, Ochoa JE, Bilo G, Mattaliano P, Salvi P, Kario K, Lombardi C. Obstructive sleep apnea syndrome as a cause of resistant hypertension. Hypertension research: official journal of the Japanese Society of Hypertension. Jul 2014;37(7):601-613.

Park JG, Ramar K, Olson EJ. Updates on definition, consequences, and management of obstructive sleep apnea. Mayo Clinic proceedings. Jun 2011;86(6):549-554; quiz 554-545.

Pedrosa RP, Drager LF, Gonzaga CC, Sousa MG, de Paula LK, Amaro AC, . . . Lorenzi-Filho G. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. Nov 2011;58(5):811-817.

Pepin JL, Borel AL, Tamisier R, Baguet JP, Levy P, Dauvilliers Y. Hypertension and sleep: Overview of a tight relationship. Sleep medicine reviews. Mar 15 2014.

Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. May 1 2013;177(9):1006-1014.

Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. Jama. Dec 20 2000;284(23):3015-3021.

Perez-Rico C, Gutierrez-Diaz E, Mencia-Gutierrez E, Diaz-de-Atauri MJ, Blanco R. Obstructive sleep apnea-hypopnea syndrome (OSAHS) and glaucomatous optic neuropathy. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. Sep 2014;252(9):1345-1357.

Phillips BA, Schmitt FA, Berry DT, Lamb DG, Amin M, Cook YR. Treatment of obstructive sleep apnea. A preliminary report comparing nasal CPAP to nasal oxygen in patients with mild OSA. Chest. Aug 1990;98(2):325-330.

Pickett CK, Regensteiner JG, Woodard WD, Hagerman DD, Weil JV, Moore LG. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. Journal of applied physiology (Bethesda, Md. : 1985). Apr 1989;66(4):1656-1661.

Pillar G, Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes care. Feb 2008;31 Suppl 2:S303-309.

Pimenta E, Stowasser M, Gordon RD, Harding SM, Batlouni M, Zhang B, . . . Calhoun DA. Increased dietary sodium is related to severity of obstructive sleep apnea in patients with resistant hypertension and hyperaldosteronism. Chest. Apr 2013;143(4):978-983.

Popovic RM, White DP. Upper airway muscle activity in normal women: influence of hormonal status. J Appl Physiol (1985). Mar 1998;84(3):1055-1062.

Pranathiageswaran S, Badr MS, Severson R, Rowley JA. The influence of race on the severity of sleep disordered breathing. J Clin Sleep Med. Apr 15 2013;9(4):303-309.

Proczko MA, Stepaniak PS, de Quelerij M, van der Lely FH, Smulders JF, Kaska L, Soliman Hamad MA. STOP-Bang and the effect on patient outcome and length of hospital stay when patients are not using continuous positive airway pressure. Journal of anesthesia. Dec 2014;28(6):891-897.

Quan Z, Liu J, Xie Y, Lei Z, Liang B, Jiang L, Tang H. [Correlation of smoking and obstructive sleep apnea and hyponea syndrome]. Zhonghua yi xue za zhi. Mar 18 2014;94(10):733-736.

Ramirez JM, Garcia AJ, 3rd, Anderson TM, Koschnitzky JE, Peng YJ, Kumar GK, Prabhakar NR. Central and peripheral factors contributing to obstructive sleep apneas. Respir Physiol Neurobiol. Nov 1 2013;189(2):344-353.

Redline S, Tishler PV, Tosteson TD, Williamson J, Kump K, Browner I, . . . Krejci P. The familial aggregation of obstructive sleep apnea. American journal of respiratory and critical care medicine. Mar 1995;151(3 Pt 1):682-687.

Remmers J, Charkhandeh S, Grosse J, Topor Z, Brant R, Santosham P, Bruehlmann S. Remotely controlled mandibular protrusion during sleep predicts therapeutic success with oral appliances in patients with obstructive sleep apnea. Sleep. Oct 2013;36(10):1517-1525, 1525a.

Roddy E, Muller S, Hayward R, Mallen CD. The association of gout with sleep disorders: a cross-sectional study in primary care. BMC musculoskeletal disorders. 2013;14:119.

Romem A, Romem A, Koldobskiy D, Scharf SM. Diagnosis of obstructive sleep apnea using pulse oximeter derived photoplethysmographic signals. J Clin Sleep Med. Mar 15 2014;10(3):285-290.

Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK. Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest. Mar 2010;137(3):711-719.

Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG. Selenium: Biochemical Role as a Component of Glutathione Peroxidase. Science (New York, N.Y.). February 9, 1973 1973;179(4073):588-590.

Sadasivam K, Patial K, Vijayan VK, Ravi K. Anti-oxidant treatment in obstructive sleep apnoea syndrome. Indian J Chest Dis Allied Sci. Jul-Sep 2011;53(3):153-162.

Sahota PK, Jain SS, Dhand R. Sleep disorders in pregnancy. Current opinion in pulmonary medicine. Nov 2003;9(6):477-483.

Salas-Salvado J, Bullo M, Estruch R, Ros E, Covas MI, Ibarrola-Jurado N, . . . Martinez-Gonzalez MA. Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial. Annals of internal medicine. Jan 7 2014;160(1):1-10.

Salles C, Terse-Ramos R, Souza-Machado A, Cruz AA. Obstructive sleep apnea and asthma. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia. Sep-Oct 2013;39(5):604-612.

Sanchez AI, Martinez P, Miro E, Bardwell WA, Buela-Casal G. CPAP and behavioral therapies in patients with obstructive sleep apnea: effects on daytime sleepiness, mood, and cognitive function. Sleep medicine reviews. Jun 2009;13(3):223-233.

Sarberg M, Svanborg E, Wirehn AB, Josefsson A. Snoring during pregnancy and its relation to sleepiness and pregnancy outcome - a prospective study. BMC pregnancy and childbirth. 2014;14:15.

Sariman N, Levent E, Aksungar FB, Soylu AC, Bektas O. Homocysteine levels and echocardiographic findings in obstructive sleep apnea syndrome. Respiration; international review of thoracic diseases. 2010;79(1):38-45.

Scanlan MF, Roebuck T, Little PJ, Redman JR, Naughton MT. Effect of moderate alcohol upon obstructive sleep apnoea. The European respiratory journal. Nov 2000;16(5):909-913.

Schlatzer C, Schwarz EI, Kohler M. The effect of continuous positive airway pressure on metabolic variables in patients with obstructive sleep apnoea. Chronic respiratory disease. Feb 2014;11(1):41-52.

Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Doring F. Functions of coenzyme Q10 in inflammation and gene expression. BioFactors (Oxford, England). 2008;32(1-4):179-183.

Schwab RJ, Remmers JE, Kuna ST. Chapter 101 - Anatomy and Physiology of Upper Airway Obstruction. In: Dement MHKRC, ed. Principles and Practice of Sleep Medicine (Fifth Edition). Philadelphia: W.B. Saunders; 2011:1153-1171.

Schwartz AR, Patil SP, Laffan AM, Polotsky V, Schneider H, Smith PL. Obesity and obstructive sleep apnea: pathogenic mechanisms and therapeutic approaches. Proceedings of the American Thoracic Society. Feb 15 2008;5(2):185-192.

Scorza FA, Cavalheiro EA, Scorza CA, Galduroz JC, Tufik S, Andersen ML. Sleep Apnea and Inflammation - Getting a Good Night's Sleep with Omega-3 Supplementation. Front Neurol. 2013;4:193.

Seda G, Tsai S, Lee-Chiong T. Medication effects on sleep and breathing. Clin Chest Med. Sep 2014;35(3):557-569.

Seetho IW, Wilding JP. Screening for obstructive sleep apnoea in obesity and diabetes--potential for future approaches. Eur J Clin Invest. Jun 2013;43(6):640-655.

Seneviratne U, Puvanendran K. Excessive daytime sleepiness in obstructive sleep apnea: prevalence, severity, and predictors. Sleep medicine. Jul 2004;5(4):339-343.

Shahar E, Redline S, Young T, Boland LL, Baldwin CM, Nieto FJ, . . . Robbins JA. Hormone replacement therapy and sleep-disordered breathing. Am J Respir Crit Care Med. May 1 2003;167(9):1186-1192.

Shantha GP, Pancholy SB. Effect of renal sympathetic denervation on apnea-hypopnea index in patients with obstructive sleep apnea: a systematic review and meta-analysis. Sleep & breathing = Schlaf & Atmung. May 17 2014.

Silva GE, Vana KD, Goodwin JL, Sherrill DL, Quan SF. Identification of patients with sleep disordered breathing: comparing the four-variable screening tool, STOP, STOP-Bang, and Epworth Sleepiness Scales. Journal of clinical sleep medicine: JCSM: official publication of the American Academy of Sleep Medicine. Oct 15 2011;7(5):467-472.

Singh TD, Patial K, Vijayan VK, Ravi K. Oxidative stress and obstructive sleep apnoea syndrome. The Indian journal of chest diseases & allied sciences. Oct-Dec 2009;51(4):217-224.

Skinner MA, Kingshott RN, Filsell S, Taylor DR. Efficacy of the 'tennis ball technique' versus nCPAP in the management of position-dependent obstructive sleep apnoea syndrome. Respirology (Carlton, Vic.). Sep 2008;13(5):708-715.

Smach MA, Naffeti S, Charfeddine B, Ben Abdallah J, Othmen LB, Letaef A, Limem K. [Homocysteine, vitamin B-12, folic acid and the cognitive decline in the elderly]. Pathologie-biologie. Oct 2013;61(5):184-192.

St John WM, Bartlett D, Jr., Knuth KV, Knuth SL, Daubenspeck JA. Differential depression of hypoglossal nerve activity by alcohol. Protection by pretreatment with medroxyprogesterone acetate. The American review of respiratory disease. Jan 1986;133(1):46-48.

Stadler DL, McEvoy RD, Sprecher KE, Thomson KJ, Ryan MK, Thompson CC, Catcheside PG. Abdominal compression increases upper airway collapsibility during sleep in obese male obstructive sleep apnea patients. Sleep. Dec 2009;32(12):1579-1587.

Stasche N. Selective indication for positive airway pressure (PAP) in sleep-related breathing disorders with obstruction. GMS current topics in otorhinolaryngology, head and neck surgery. 2006;5:Doc06.

Stein MD, Friedmann PD. Disturbed sleep and its relationship to alcohol use. Substance abuse: official publication of the Association for Medical Education and Research in Substance Abuse. Mar 2005;26(1):1-13.

Strohl KP. The Merck Manual online. Sleep Apnea. Obstructive Sleep Apnea. Available at: Last updated 11/2013. Accessed 1/19/2015.

Strollo PJ, Jr., Soose RJ, Maurer JT, de Vries N, Cornelius J, Froymovich O, . . . Strohl KP. Upper-airway stimulation for obstructive sleep apnea. N Engl J Med. Jan 9 2014;370(2):139-149.

Sutherland K, Lee RW, Cistulli PA. Obesity and craniofacial structure as risk factors for obstructive sleep apnoea: impact of ethnicity. Respirology. Feb 2012;17(2):213-222.

Tamanna S, Geraci SA. Major sleep disorders among women: (women's health series). Southern medical journal. Aug 2013;106(8):470-478.

Tasali E, Van Cauter E, Ehrmann DA. Polycystic Ovary Syndrome and Obstructive Sleep Apnea. Sleep medicine clinics. Mar 2008;3(1):37-46.

Thomopoulos C, Spanoudi F, Kyriazis I, Anastasopoulos I, Ioannidis I. Metabolic effects of renal denervation. Current clinical pharmacology. Aug 2013;8(3):206-211.

Thompson AB. First Consult. Obstructive sleep apnea. Available at: Last updated 9/18/2012. Accessed 11/25/2014.

Tien DA, Kominsky A. Managing snoring: When to consider surgery. Cleve Clin J Med. Oct 2014;81(10):613-619.

Toledo E, Hu FB, Estruch R, Buil-Cosiales P, Corella D, Salas-Salvado J, . . . Martinez-Gonzalez MA. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC medicine. 2013;11:207.

Tomfohr LM, Ancoli-Israel S, Loredo JS, Dimsdale JE. Effects of continuous positive airway pressure on fatigue and sleepiness in patients with obstructive sleep apnea: data from a randomized controlled trial. Sleep. Jan 2011;34(1):121-126.

Tse HN, Tseng CZ. Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease. 2014;9:825-836.

Ukena C, Mahfoud F, Ewen S, Cremers B, Laufs U, Bohm M. Renal denervation in the treatment of hypertension. Current hypertension reports. Aug 2013;15(4):363-369.

UMMC. University of Maryland Medical Center. Obstructive Sleep Apnea. Available at: Last updated 09/18/2013a. Accessed 10/05/14.

UMMC. University of Maryland Medical Center. Sleep Apnea. Available at: Last updated 05/07/2013b. Accessed 10/05/2014.

Vakulin A, Baulk SD, Catcheside PG, Antic NA, van den Heuvel CJ, Dorrian J, McEvoy RD. Effects of alcohol and sleep restriction on simulated driving performance in untreated patients with obstructive sleep apnea. Ann Intern Med. Oct 6 2009;151(7):447-455.

Valipour A. Gender-related differences in the obstructive sleep apnea syndrome. Pneumologie (Stuttgart, Germany). Oct 2012;66(10):584-588.

Van de Heyning PH, Badr MS, Baskin JZ, Cramer Bornemann MA, De Backer WA, Dotan Y, . . . Woodson BT. Implanted upper airway stimulation device for obstructive sleep apnea. The Laryngoscope. Jul 2012;122(7):1626-1633.

Venn BJ, Green TJ, Moser R, Mann JI. Comparison of the effect of low-dose supplementation with L-5-methyltetrahydrofolate or folic acid on plasma homocysteine: a randomized placebo-controlled study. The American journal of clinical nutrition. Mar 2003;77(3):658-662.

Wang XH, Xiao LY, Wang BF, Yuan YD, Pan WS, Shi YZ. Influence of auricular plaster therapy on sleeping structure in OSAS patients. Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan / sponsored by All-China Association of Traditional Chinese Medicine, Academy of Traditional Chinese Medicine. Mar 2009;29(1):3-5.

Wang XH, Yuan YD, Wang BF. [Clinical observation on effect of auricular acupoint pressing in treating sleep apnea syndrome]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. Oct 2003;23(10):747-749.

Weaver TE, Mancini C, Maislin G, Cater J, Staley B, Landis JR, . . . Kuna ST. Continuous positive airway pressure treatment of sleepy patients with milder obstructive sleep apnea: results of the CPAP Apnea Trial North American Program (CATNAP) randomized clinical trial. American journal of respiratory and critical care medicine. Oct 1 2012;186(7):677-683.

Weaver TE, Sawyer AM. Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions. The Indian journal of medical research. Feb 2010;131:245-258.

Wesstrom J, Ulfberg J, Nilsson S. Sleep apnea and hormone replacement therapy: a pilot study and a literature review. Acta Obstet Gynecol Scand. Jan 2005;84(1):54-57.

Wickwire EM, Lettieri CJ, Cairns AA, Collop NA. Maximizing positive airway pressure adherence in adults: a common-sense approach. Chest. Aug 2013;144(2):680-693.

Wiener RC, Shankar A. Association between Serum Uric Acid Levels and Sleep Variables: Results from the National Health and Nutrition Survey 2005-2008. International journal of inflammation. 2012;2012:363054.

Witkowski A, Prejbisz A, Florczak E, Kadziela J, Sliwinski P, Bielen P, . . . Januszewicz A. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension. Oct 2011;58(4):559-565.

Wittert G. The relationship between sleep disorders and testosterone. Current opinion in endocrinology, diabetes, and obesity. Jun 2014;21(3):239-243.

Wu YH, Wei YC, Tai YS, Chen KJ, Li HY. Clinical outcomes of traditional Chinese medicine compound formula in treating sleep-disordered breathing patients. The American journal of Chinese medicine. 2012;40(1):11-24.

Xu J, Niu YX, Piao XM, Liu Z, Wu LZ, Liang RL. [Effect of acupuncture on blood oxygen saturation in patients of obstructive sleep apnea-hypopnea syndrome]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion. Jan 2009;29(1):84-86.

Yalamanchali S, Farajian V, Hamilton C, Pott TR, Samuelson CG, Friedman M. Diagnosis of obstructive sleep apnea by peripheral arterial tonometry: meta-analysis. JAMA otolaryngology-- head & neck surgery. Dec 2013;139(12):1343-1350.

Yen CM, Kuo CL, Lin MC, Lee CF, Lin KY, Lin CL, . . . Kao CH. Sleep disorders increase the risk of osteoporosis: a nationwide population-based cohort study. Sleep Med. Aug 1 2014.

Yu JC, Berger P, 3rd. Sleep apnea and obesity. South Dakota medicine: the journal of the South Dakota State Medical Association. 2011;Spec No:28-34.

Zhang XB, Jiang XT, Du YP, Yuan YT, Chen B. Efficacy of continuous positive airway pressure on testosterone in men with obstructive sleep apnea: a meta-analysis. PloS one. 2014;9(12):e115033.

Zhao MM, Tan XX, Ding N, Zhang XL. [Comparison of efficacy between continuous positive airway pressure and renal artery sympathetic denervation by radiofrequency ablation in obstructive sleep apnea syndrome patients with hypertension]. Zhonghua yi xue za zhi. Apr 23 2013;93(16):1234-1237.

Ziegler MG, Milic M, Elayan H. Cardiovascular Regulation in Obstructive Sleep Apnea. Drug Discov Today Dis Models. Winter 2011;8(4):155-160.